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Chapter 1
INTRODUCTION
It is the basic tenet of research in the natural sciences that theory has to be
validated by experimental data[Fey67]. In an iterative process, experiment and
observation yield data, which is then organized and becomes theory. The theory
in turn leads to new experiments.
Currently the field of biology in the main and of signal transduction in
particular is preoccupied with data-collection, and the overall signaling system
is still unknown. What we have is a hodge-podge of individual observations. The
situation is akin to the one chemists faced in the eighteenth century: the amount
of data generated was unwieldy and it was difficult to make sense of it. It was
not before the periodic table was created, which was based on that raw data and
made a system evident in those observations, that a model could be developed
to explain the multitude of phenomena by a set of general rules. By analogy, the
data generated today by biologists is collected in structured repositories, and
the hope is that one day, based on this data, it will be possible to explain the
logic of signal transduction, gene expression patterns, development and cancer.
Physics makes use of mathematics to develop its models, and while the
mathematics used is often straightforward from a mathematician’s point of view,
from the marriage between the two disciplines new insight emerges. Biology
deals with systems more complicated and messy than those of physics, and this
has made useful mathematical formalization of biological systems difficult to
date. Instead, computer databases are used to integrate the knowledge, and
while the informatics used are straightforward from an informatician’s point of
view, from the marriage between the two disciplines a new way of dealing with
biological data and doing research has emerged.
1.1 Motivation
Cells, especially those of a complex multicellular organism, have to react to each
other and to external influences in a well-concerted manner. If we want to under-
stand cellular behavior and its responses to external signals, or want to influence
it in a predictable manner, we have to understand the pathways through which
these signals are mediated into and within the cell. Biological signaling path-
ways also interact with each other to form complex networks. These networks
show emergent properties like signal integration or self-sustaining feedback loops
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which are not present in the isolated pathways [BI99].
In most cases changes in cell behavior involve the execution of transcrip-
tional events, which are specific for each signal in its cellular context [HT95].
Signal transduction pathways regulate the activity of many transcription factors
[Mon97]. The transcription factors in turn are organized in gene-regulatory net-
works, and the genes expressed can also feed back into the signal transduction
network.
Knowledge about the principle mechanisms of signal transduction and regu-
lation mechanisms of individual macromolecules in signaling pathways has mul-
tiplied in the last decade. It is now growing at a rate that makes it difficult to
keep up with [Kra97]. The huge and ever more rapidly growing amount of signal
transduction data demands a database that stores and organizes this knowledge,
providing simple and fast access to the information. The complexity created by
the crosstalk between pathways makes it virtually impossible to infer by hand
all the consequences that follow after one modifies one part of the network. To
this end, computer-aided analysis and simulation will have to be used. It can
only be successful on the basis of a comprehensive and detailed dataset.
The main purpose of this work is the design of a database for the available
data on signal transduction. This database should be usable for two purposes: to
provide an information resource for researchers interested in signal transduction
and to serve as the basis for automated analysis and simulation work.
Today, a big part of our knowledge about signal transduction is still of a
qualitative, indirect nature. The knowledge is fragmented in thousands of single
observations, and it is a time-consuming and difficult process to get an overview
about it from reading primary literature.
In scientific review papers, graphics like Fig. 1.1 are published to provide
an integrated view of the signal pathways.
Analyses of cellular function, termed functional genomics and functional
proteomics will be the next big challenge for the whole field of biosciences in
the years to come. The function of a molecule has no meaning on its own.
Only context gives meaning to the function, and so we try to understand the
interactions of each molecule with other molecules. Among many other things,
data on signal transduction will be a necessity for this to succeed.
Cancer is the pathological deregulation of cell growth, resulting in uncon-
trolled proliferation. Practically all oncogenes encode aberrantly functioning
members of signal transduction pathways coupled to growth-regulating sig-
nals [EW93] that then constitutively switch on transcription. It has been
shown[HW00] that a multitude of genes can play a role in oncogenic trans-
formation of cells and that mutation in a single gene alone is not sufficient to
induce cancer. Having information about alternate pathways and the interac-
tion between pathways will help to understand abnormal behavior and to target
critical elements in pathways for medical treatment.
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Figure 1.1: Network representation in review literature. Depiction of the cell
signaling network in respect of cancer.[HW00] Point arrows are activating reac-
tions, bar-ended arrows are inhibiting ones. Inhibiting arrows in some cases are
shown to act on molecules, in other cases they act on reactions.
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Keyword Number in human Number over all species
SIGNAL 1551 18161
HORMONE 58 953
GROWTH FACTOR 105 589
NEUROTRANSMITTER 30 162
IONIC CHANNEL 147 1357
RECEPTOR 279 4565
G-PROTEIN 227 1357
KINASE 74 4425
TRANSCRIPTION 515 5761
ALL 2986 37330
Table 1.1: Number of signaling proteins found in the SWISS-PROT protein
database, public release Nr. 36. Proteins in SWISS-PROT are labeled with
keywords. For example, 1551 entries for human were labeled with the keyword
SIGNAL.
1.2 Biological signal transduction
What follows is a short outline of well-studied signal transduction principles,
molecules and pathways. It will become clear that the means of signal trans-
duction are nearly as varied as the number of pathways.
Biological signaling is performed by the interaction between signaling mole-
cules, and most of them are proteins. Table 1.1 gives an overview of the amount
of signaling proteins found in the SWISS-PROT database [BA00]. A lot of the
annotation in this database is by homology to experimentally confirmed results.
Many pathways that are known today have been assembled from experiments
in different model organisms, and checked for humans only with sequence ho-
mology comparison of the genes involved. Especially with vertebrates, all major
pathways seem to be strongly conserved [OG98].
Judging from the 5908 entries that are in SWISS-PROT for human, com-
pared to the estimated thirty thousand human genes [V+01], this number is one
order of magnitude too small. We can expect more than ten thousand proteins
to be involved in signal transduction and gene regulation in humans.
1.2.1 Signal hierarchies
Multicellular organisms are highly complex systems. To handle this complexity
they are built in a hierarchical manner, and signaling networks exist on several
levels of this hierarchy. On the highest level, intercellular signaling via hormones
and other factors coordinates the activities of the different organs and tissues.
Then, inside the cell the signal transduction network translates the hormonal
inputs into outputs that may result in a changed state of the cell or the secretion
of other messengers. Inside the cellular nucleus, the transduced signal in turn
serves as input for a gene regulatory network and may lead to the expression of
other genes as output to the signaling network.
To insulate the different networks from each other, several mechanisms exist.
The most important one is spatial compartmentalization: the various networks
of signaling molecules exist in spaces which are separated by membranes like
1.2. BIOLOGICAL SIGNAL TRANSDUCTION 7
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Plasma membrane
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Figure 1.2: Compartimental hierarchies. Signal transduction connects gene-
regulatory and intercellular networks.
the plasma or nuclear membrane (Fig.1.2). They interact only at well defined
and strongly regulated ports, like receptor or channel proteins.1
Another insulation mechanism may be time-scale decoupling [RCPO¨99].
Times of processes in the cell vary significantly from seconds in enzymatic catal-
ysis or even femtoseconds in photosynthetic excitation to dozens of minutes for
protein expression and even days or weeks for hormone responses. Slower pro-
cesses are insensitive to the values of fast-changing processes, seeing only their
averaged value.
While it is clear that to fully understand cellular behavior in multicellular
organisms, it will be necessary to include the inter-cellular signaling relations in
the model, our focus is on intracellular signalling.
1.2.2 Signaling motifs
The molecule is not the smallest unit that interacts in signaling networks. Many
proteins are large and have themselves a modular composition, consisting of
several domains. The domains in turn can feature motifs, specific three dimen-
sional structures. Motifs are responsible for the signaling properties and work
somehow independently from the rest of the protein [CRB95, LFSSC93].
Compartmentalization does not stop at the subcellular compartment level.
Eukaryotic cells have evolved scaffolding and adapter proteins using motifs to
simultaneously bind multiple components of a signaling pathway and thereby
impose a degree of specificity and order on the highly connected network of
signaling molecules.
Scaffolding insulates these molecules and may diminish cross-talk to other
pathways. It makes possible a new degree of signal amplification and speed,
which could not be achieved with molecules freely distributed in the cytoplasm
and relying on diffusion to collide and interact every now and then.
1This can be compared to the use of modules and composition in programming. Object-
oriented programming incorporates ideas seen in biological systems to handle complexity
[Boo94]: you have subsystems with strong interactions or coupling within, but weaker inter-
actions or coupling between subsystems, over well defined interfaces. The overall system is
more robust, as changes in one subsystem do not influence the others strongly.
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Domains can be shuﬄed between proteins by evolutionary genetic mecha-
nisms, leading to new composites that may integrate signals in a new way.
1.2.3 Extracellular signaling
Extracellular molecules are recognized by specific receptors on the surface of
or within the cell. Since receptors have to detect low concentrations of signal
molecules (nanomolar or smaller), they are highly sensitive.
Different kinds of cells have different sets of receptors, and thus can react to
different signals. Several signals can be integrated in the cell into a combined
signal, and so the combination of a limited amount of messengers can create a
vast number of messages.
Different kinds of cells can react differently to the same signal, because they
have different interior signal transduction pathways hooked up to the same
receptor.
For example acetylcholine makes skeletal muscle contract, but heart muscle
decontract, as they use different receptors. It makes secretory cells secrete, even
though these have the same receptor as heart muscle, because in this case that
same receptor is hooked up to different pathways.
Extracellular signals can be classified according to their chemical composi-
tion, to their method of action or to the range and time over which they transfer
the signal. The most important ones are hormones and cell surface molecules.
Cell surface molecules are proteins, and many are glycosylated. They are
presented on the surface of cells and bind to receptors on the surface of
neighboring cells, acting locally.
Local regulators are molecules that also act locally but are soluble and diffuse
through the intercellular space. Some examples are neurotransmitters in
synapses, interleukines and nitric oxide, a gas that diffuses through the
cell membrane.
Hormones are chemical signals that diffuse systemically, carried by blood and
lymph. They can broadly be sub-categorized into
1. Hydrophilic molecules like proteins, small peptides, nucleotides, amino
acids or their derivatives. They cannot cross the plasma membrane
and have to bind to receptors on the cell surface. Usually they have
a half-life in blood of several minutes. Short-lived ones also serve as
local regulators.
2. Small hydrophobic molecules like steroid hormones, thyroid hormones
and retinoids. Bound to carrier molecules, they can travel through
the blood stream for hours, thyroid hormones even for days. Finally,
they diffuse though the plasma membrane of their target cells, and
bind to intracellular receptors.
1.2.4 Receptors
Receptors provide the interface between extracellular and intracellular signaling.
The signal molecules, which are called ligands in this context, attach to the
receptors and thereby are localized to the cell. By analogy with the different
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kinds of signal molecules, we have two fundamentally different kinds of receptors,
the first kind are the cell surface receptors. They bind hydrophilic molecules
and there are three major classes:
G-protein-coupled receptors form a family with over 100 members. All are
coupled to a G-protein, which, upon binding of ligand, dissociates into
subunits, which are freed and go on to activate target proteins in the cell,
like enzymes or ion channels.
Catalytic receptors are either enzymes, or associated with enzymes. The
group is heterogeneous, although most of them act as tyrosine protein
kinases. The catalytic function is activated upon ligand binding, usually
by dimerization and autophosphorylation.
Ion-channel-coupled receptors are also called transmitter-dependent ion-
channels and take part in the fast synaptic signal process mediated by
neurotransmitters. Upon binding of ligand, they open the ion channel.
The second kind of receptors are the intracellular receptors, which bind hy-
drophobic molecules that are able to pass the cell membrane. Some of these
receptors are bound to an inhibitory protein complex, which masks the DNA
binding region or prevents their translocation into the nucleus. Upon bind-
ing of ligand, they dissociate from the complex, form homo- or, more often,
heterodimers, and bind to DNA. These receptors are built in a modular way,
consisting of a short DNA-binding domain, a ligand binding domain and a
transcription-activating domain.
1.2.5 Intracellular signaling
The means of intracellular signal processing are just as diverse as the various
ways of acknowledging the signal. In many cases the signal leads to a transient
modification of signaling molecules downstream in the pathway, which changes
their state from inactive to active.
G-proteins exchange GDP with GTP upon stimulation by cell surface recep-
tors. The GTP-bound form is active and dissociates from the receptor.
The autocatalytic activity of the G-protein finally hydrolyzes GTP to
GDP and phosphate again, turning the signal off. Active G-proteins have
a range of effects, depending on the type of the G-protein. Gs for example
activates adenylyl cyclase, which in turn transforms ATP to cAMP and
phospholipase Cβ, which splits PIP2 to IP3 and diacyl glycerol.
Adapter proteins can bind to structural motifs of several other proteins, col-
lecting them into spatial proximity. This assembly may serve to localize
some proteins to certain areas in the cell or to aid in their interaction.
Second Messengers are non-protein molecules that participate in the intra-
cellular transduction of a signal. The name stems from the extracellular
signal molecule that binds to the membrane receptor and is a pathway’s
’first messenger’. A major advantage of second messengers is their small
size and water solubility that allows rapid diffusion throughout a cell’s
cytoplasm. The most important ones are IP3, calcium and cAMP. cAMP
for example activates protein kinase A.
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Protein kinases are enzymes that phosphorylate target proteins. About 1%
of our genes is thought to code for them and a single mammalian cell might
have more than 100 different active ones. Most kinases inside the cell are
serine/threonine kinases (S/T kinases). They phosphorylate proteins on
their serine or, sometimes, threonine side chains. The phosphorylation
changes the structure and behavior of the target. Prominent examples are
protein kinase A, protein kinase Cβ and Cγ, mitogen activated kinase.
Most tyrosine kinases (Y kinases) are receptors or receptor associated.
Protein phosphatases catalyze the reverse reaction of phosphorylation, the
hydrolytic removal of a phosphate added to a protein. The important
function of protein phosphatases is that they introduce reversibility to the
protein-kinase-mediated phosphorylation of a protein, thus contributing
to the dynamic nature of a cell.
Transcription factors are proteins that bind to a cis-regulatory element on
the DNA and thereby, directly or indirectly, affect the initiation of tran-
scription. Prominent examples are CREB, NF-κB or AP-1.
1.2.6 Nature of the cytosol
The cytosol is the matrix which occupies the space between the organelles in
the cytoplasm. At one time it was thought to be a fluid unstructured matrix
consisting of soluble enzymes, low molecular weight metabolites, ions and water.
It is now known to have a more viscous, gel-like nature. About 20% of the cell’s
wet weight are protein.[Seg75] This is in sharp contrast with the highly diluted,
well stirred aqueous solution that is assumed when considering classical reaction
dynamics between solubilized molecules.
In addition, some molecules may only be present in a low number of copies.
Both these facts make it difficult to apply the classical framework of reaction
kinetics in this environment, as the basic assumptions used to derive it do not
hold.
Since rate constants are usually measured in diluted aqueous solution in
vitro, it is questionable how justified it is to apply them to the situation in the
cell. They are used as these data are the only ones available.
1.3 Object-Oriented Databases
An object-oriented database management system (OODBMS) is a DBMS that
makes use of principles derived from object-oriented programming. The first cri-
terion translates into five features: persistence, secondary storage management,
concurrency, recovery, and ad hoc query facility. The second one translates
into eight features: object identity, complex objects, encapsulation, types or
classes, inheritance, overriding combined with late binding, extensibility and
computational completeness [ABD+95].
The features typical for database management systems are:
Persistence is the ability of the programmer to have the data survive the exe-
cution of a process. In OODB, each object is allowed to become persistent
independent of its type without explicit casting.
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Secondary Storage Management means performance features, such as in-
dex management, data clustering, data buffering, access-path selection,
and query optimization, which are hidden to the user.
Concurrency is the ability of the DBMS to offer all users working simultane-
ously the same level of service.
Recovery means the software is able to bring the data back to some coherent
state in case of hardware or software failure.
Object-oriented features are the features found in objects of modern object-
oriented programming languages. It is necessary to support these if we want to
store and retrieve the language objects transparently.
Object Identity means the object-oriented model is identity-based, each ob-
ject has an object identity (OID) which uniquely identifies this object,
independent of the values stored within. The OIDs are issued and man-
aged by the OODBMS.
Complex Objects are built from simpler ones. The use of complex objects
improves the capability of representing the real world. One important
feature of object-oriented databases is navigation by reference. This means
that the objects in the database contain pointers to each other. If one
object is referencing another one, we can get the second object directly by
resolving the reference, instead of posing a query for its OID.
Encapsulation means that an object contains both programs and data and
offers to the world an interface hiding the implementation part. The inter-
face part is the specification of the set of operations that can be performed
on the object; the implementation part describes the implementation of
each operation. In most OODB, even data specification is part of the
interface.
Types summarize the common features of sets of objects. A type can be consid-
ered a set of values and a set of operations on those values. This can insure
type-safe programming. However, the representation of types, classes, can
be separated from the notion of type allowing many representations per
type while still maintaining reasonable type-safety. Also, one class can
implement several types, as long as it satisfies the requirements defined
by those types. Classes serve as templates to produce objects, an object
is an instance of a class. For most practical purposes, types and classes
are equivalent.
Inheritance is the ability of a subclass to receive all data and operations com-
ing from its superclasses. It helps to achieve code reusability, and leads
to a better-structured and more concise description of the real world and
the shared specifications of applications.
Overriding, Overloading and Late Binding : When a single identifier is
bound to different operation codes in different types we say that the code
is overridden. When the identifier name is identical but the parameters
differ the operation is overloaded. To provide this functionality, code is not
bound to operation identifiers at compile time but at run time, performing
the so called late binding.
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Extensibility : Predefined and user-defined types must have the same status.
They must be supported by the system as completely equivalent.
The standard for object databases is the ODMG Standard [Ce97]. It is
a de-facto standard published by the Object Database Management Group, a
consortioum of representatives for the major object-oriented database manufac-
turers. Adherence to the standard varies significantly between vendors. The
ODMG Standard covers areas such as the Object Model and how it relates
to the OMG object model, Object Specification Languages, the Object Query
Language (OQL) and language bindings for C++, Smalltalk and Java.
In general, data in databases can be related by one-to-one, one-to-many and
many-to-many relations. In biology, most relations tend to be of the last variety.
To implement many-to-many relations between two types in an object oriented
database collection attributes in one of these types are used.
Chapter 2
RESULTS
2.1 Data model for the signaling network
This section outlines the central design of the database structure, presenting
in detail some of the classes that make up the structure and discussing design
decisions. A full class layout and detailed descriptions of all classes can be found
online under http://transpath.gbf.de/intro/tech/api. The database im-
plemented with this structure has been named Transpath.
In this thesis, a path is a linear series of interactions and molecules that
connects two molecules. A pathway is the sum of all such paths downstream or
upstream of a molecule. A network consists of all molecules and reactions that
are somehow connected. 1.
The obvious representation of a network is a graph. Compared to storing
the network as a number of predefined paths or pathways, it has the advantage
that there is a sound mathematical and algorithmic background that can be
used for analysis.
Thus, the model is essentially a big graph. Since molecules and their reac-
tions are the objects of interest, they will form the nodes. The resulting graph
is directed and bipartite, with one node type for the molecules and one for
the reactions, and edges for the connections between them. Fig. 2.1 shows an
example for such a graph, that has been enhanced by family relationships.
2.2 Querying the signaling network
To make a database usable, it must be possible to retrieve the data of interest.
The system must be able to answer questions the user has about the data.
Elementary questions that we can ask about signal transduction data include:
• Are items with a certain property, or combination of properties, in the
database? How many? What are these items? For example, the user could
search for all molecules that match a name, or contain a certain amino-
acid sequence. He could search for all molecules that have references by a
favourite author, or that have a minimum number of incoming reactions.
1Compare [KZL99] for a similar definition
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aggregation
dissociation
catalysis
cascades
families: special
behaviour of a member
families:
abstraction of members
Figure 2.1: A simple network
• What are the differences and similarities in the networks between two
different species, or cell types? For example the user could compare the
known networks of mouse and human to find signal molecules that are
missing in only one of them, and use that as a hint to look for the under-
lying genes in the other.
and
• What does the network around, upstream or downstream of a certain
molecule look like? For example, the user could be interested in the down-
stream signals mediated by a certain receptor, or in the upstream pathway
that regulates a transcription factor of interest. He could want to see the
reaction environment around a central signaling compound like PKA, to
better understand the context in which it functions.
• Is there a path between two molecules in the database, and if so, what does
it look like? Are there alternative paths? Is there a bottleneck through
which all those paths lead? What is the shortest path? For example,
the user could search for paths between a certain hormone and a certain
transcription factor. He could look for a molecule which occurs in all these
paths to find a point where a knock-out mutation might be sucessful in
breaking that connection.
• Do the paths downstream of two components meet at some point? For
example, the user could search for such crosstalk points for certain com-
binations of ligands that together show a different cellular response than
each one alone.
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For tabulated data stored in a relational DBMS, the SQL standard [SQL97]
has been established as a query tool, and is highly successful, mainly because it
allows us to answer many of the questions about this kind of data that people
have come up with. There is an analogue language for object oriented databases,
OQL[Ce97], which implements a subset of SQL.
Other query possibilities of object-oriented databases include named objects
and navigation by reachability. Named objects are nearly useless as a query
mechanism: the user has to match the name exactly to get a positive result.
One can obtain similar results using an OQL query on a name attribute, which
in addition allows wildcard matches and use of synonyms. Querying by reference
needs additional software that implements the actual query.
Of all the questions listed above, only the first two can be answered with
the current crop of query languages. The last three questions need traversal of
the network structure, which in turn needs an equivalent of recursion and is not
in the current SQL standard. Still, they are valid and natural questions about
network data, and if we want the database to be useful to the user, we have to
find a way to answer them.
A metaphor that allows queries of this type is found in graph traversal
algorithms. I call this a pathway query, to discriminate it from the classic OQL-
like queries. The depth-first and breadth-first search algorithms[Knu97, Sed92]
create spanning trees through the network graph. Since our graph is directed, it
is possible to restrict them to process along only one direction. This approach
directly allows us to answer the first of the three questions.
Once we accept this metaphor, it is easy to extend it to allow more elaborate
and complicated kinds of queries by selecting certain nodes in the search. Two
central extensions are filters and boundaries. Filters act to highlight or select
certain nodes or paths that have been observed in the traversal, while boundaries
limit the search to a subgraph.
There are numerous criteria to decide which nodes will be chosen for filtering
or bounding. A general one is the definition of sets of molecules and reactions by
classic queries or the results from another pathway query. Another possibility
comes from the topology of the network: nodes that are within a certain distance
from a starting node, nodes that have been observed before in the search and
therefore constitute an alternative route or feedback, or nodes that have a certain
number of inputs or outputs can be selected.
When we combine the basic traversal algorithms with these selection ap-
proaches, it becomes possible to answer the last two of the three questions,
too:
For example, in the second of the three questions it is possible to first select a
transcription factor from the database, and then use it to filter all pathways that
extend downstream from some extracellular hormone, yielding only those paths
that lead from the hormone to the factor. In the last of the three questions,
one can use the downstream cascade from one component as a boundary for a
downstream cascade from the other component, and select all molecules found
on that boundary, yielding the crosstalking molecules.
To take into account family and state relationships in the database, we have
to extend the search to traverse these relations, too. Again, there should be a
possibility to limit the depth – or height – of these classification transitions.
Section 2.5.3 contains a review of the implementation of these concepts.
16 CHAPTER 2. RESULTS
2.3 Visualising the signaling network
Once we have a means to pose pathway queries, we have solved half the prob-
lem of making the data accessible. It is as important to have a metaphor for
visualizing the database contents. There are different ways to do this, and they
vary in terms of their ability to depict the network.
We provide five different views on the data, in order of increasing visualized
context:
1. tabular data that present the attributes of a single object in the database,
without further network context. (Fig. 2.12).
2. Linear paths that show an ordered list of interactions connecting two
molecules of interest. (Fig. 2.19).
3. Tree-like cascades that show which elements are downstream or upstream
of a core component. (Fig. 2.14).
4. Graph layouts that show the full network as connections between nodes,
according to its topology. (Fig. 2.17).
5. Hand drawn, clickable maps that enrich the topological layout with addi-
tional information, like subcellular location or molecule type. (Fig. 2.11).
2.4 Class layout for the Transpath database
The aim of the class layout for the database is to capture the structure of the
biological relations that are relevant for signal transduction. This section will
present my insights on the correct class hierarchy to capture signal transduction
pathways. The differences between the current prototype implementation and
this layout are discussed in chapter 4.
Suppose we represent molecules as instances of a Molecule class, and reac-
tions between them as instances of a Reaction class. If we wish to represent a
many-to-many relation between molecules and reactions, it is sufficient to pro-
vide in the Molecule class a collection attribute that can hold reactions [Heu92].
Since any molecule will have its own collection, we have achieved a many-to-
many relationship, where each molecule can refer to many reactions, and many
molecules can refer to each reaction.
Note that this relationship is directional. Starting from a given molecule,
we find the set of related reactions easily, because molecules are pointing to
reactions. Starting from a given reaction we cannot easily find the set of related
molecules, because reactions are not pointing back to molecules. To find the set
of molecules, we must examine all molecules and remember the one that pointed
to the reaction in question, which is similar to the way queries in relational
databases are used to pull together related bits of information.
One of the fundamental ideas in databases is to remove redundancy to avoid
contradiction or inconsistency. If there are two redundant items and we acci-
dentally change one of them, they will afterwards contradict each other, and
the database will be inconsistent.
To enable faster navigation by reachability in any direction, especially for
the creation of pathways, we introduce an additional, redundant collection of
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Reference
- title: String
- publication: String
- authors: String
- components: Coll of Komp.
- comments: Coll of Annotate
- accno: String
-urlbase: String
- entries: Coll of Entry
Hyperlink Annotate
- text: String 
- source: Reference
- category: String 
- components: Coll of Komp.
Location
- species: String
- tissue: String 
- celltype: String
- compartment: String
- stage: String
- components: Coll of Komp.
- negcomps: Coll of Komp.
Molecule
- sequence: String 
- type: String
- firstpos: int
- lastpos: int
- parts: Coll of Molecule
- bulks: Coll of Molecule
- catalyzes: Coll of Reaction
- inhibits: Coll of Reaction
- rkins: Coll of Reaction
- rkouts: Coll of Reaction 
- states: Coll of Molecule
- stateofs: Coll of Molecule
Reaction
- reactants:  Coll of Molecule
- produces:  Coll of Molecule
- enzymes:   Coll of Molecule
- inhibitors: Coll of Molecule
- effect: String
-constant: double
- kcat: double
- reversible: boolean
- obsolete: boolean
Komponent
# name: String
# quality: String
# fullname: String
# synonyms: String
# klass: String
# comments: Coll of Annotate 
# references: Coll of Reference
# members:Coll of Komponent
# groups: Coll of Komponent
# locations: Coll of Location
# neglocs: Coll of Location
Entry 
# id: String  
# extid: String
# creator: String 
# createdate: String
# updator: String
# update: String
# restrict: String
# remark: String
# accnos: Collection of Hyperlink
*
1
1
*
*
*
*
*
*
*
*
*
*
Enzyme
Inhibitor
Reactant
Product
Figure 2.2: UML class layout of the current implementation. Only one relation
is shown between two classes, even if several exist. For the key relations between
Molecule and Reaction the roles are given. To maintain clarity, methods for the
classes are not shown.
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Figure 2.3: Entity-relationship diagram for the Transpath database.
backreferences for each collection of references. This controlled redundancy
improves the database performance. To guard against consistency errors, we
use encapsulation: an object cannot directly be stored in or removed from these
collections, only through methods which automatically insert or remove the
cross-references on that object.
Cross-referencing is so commonplace for object-oriented databases, that it
is supported by the ODL (Object Definition Language) recommended by the
ODMG.[Ce97, KE99]
It is not possible to associate additional information with this kind of con-
nection between two items. Since the pointers that refer to the items are internal
pointers of the programming language or OODBMS, we cannot store data in
them. This is in contrast with relational databases, where it is easily possible
to extend a linking table with additional fields to store contextual information.
If we want to mimic this possibility with an object-oriented database, we have
to introduce an additional class that emulates this linking table. We do this
in the signaling class hierarchy for the central relation between Molecule and
Reaction, which needs additional properties to adequately represent the biology
(see 2.4.8 below).
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2.4.1 Entry
All classes in the database inherit from the superclass Entry. It has no biological
meaning, but allows us to reuse the fields that hold administrative information
on each entry, like who created it and when it was last modified. There are no
direct instances of this class in the database.
2.4.2 Component
The class Component represents nodes in the graph. It is the superclass of
Reaction and Molecule, and allows the reuse of fields that apply to both kinds
of nodes, like name and family membership. Component has no direct instances
in the database.2
Groups
Important attributes of all components are the collections that allow expression
of family relationships. Each Component can act as a group of other compo-
nents or as a member in such a group. In the case of Molecule, this grouping
represents family relationships between the molecules. In the case of Reaction,
this grouping can be used to assign reactions to a general class of reactions,
as is done successfully in the EC nomenclature [otIUoBB92]. The third possi-
bility is the use of mixed groups, which contain both reactions and molecules,
and correspond to nets or explicitly stated pathways. This is interesting since
it would support the appealing idea of building networks from subnets in a
modular fashion [MA97].
Locations
Each component in the network has two lists of Location objects (see 2.4.9).
One list contains all locations where experiments have affirmed the presence
of the component, the other list contains all locations where experiments have
affirmed its absence — which is neccesary to distinguish between cases where
the component is absent and cases where its status has not been investigated.
For molecules, the locations describe where the molecules have been shown to be
expressed, or have been shown to be not expressed. For reactions, the locations
describe in what kind of system the reactions have been confirmed, or have been
found not to happen.
2.4.3 Molecule
Molecules interact with each other to build pathways. A Molecule is anything
that is subject to reactions. Most Molecules have a mass, be it a small molecule
like ATP, a protein or a stretch of DNA sequence. No difference is made be-
tween receptors, enzymes, second messengers, transcription factors or other spe-
cial kinds of proteins. A Molecule can also be a group of such entities, like a
protein family, a state of such an entity, like the phosphorylated form or a com-
plex of several other Molecules. And finally a Molecule can be part of another
Molecule, either non-covalently bound as in a complex, or covalently bound as
2Component was named with a K in the Java implementation to avoid confusion with the
Java Component class.
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in a structural motif of a protein. The reason for such a wide scope for this
class is to catch anything that shows specific signaling behavior.
A molecule can serve in four fundamental roles in the context of a reaction:
it can be an educt, a product, an enzyme or a modulator. Enzyme, educt and
modulator are the inputs of the reactions, while products are the outputs. For
semantic reactions (see 2.4.7) molecules are only grouped into signal donors,
which are the inputs, and signal acceptors, which are the outputs.
We use two other collections, states and stateofs, to keep the states (see
2.4.6) separated from the family grouping hierarchy (see 2.4.5).
2.4.4 Motif
Motifs of a protein often are responsible for its signaling behavior (see [Hun00]).
A single protein can have several signaling motifs, and some motifs are shared
by several proteins. Sometimes, a motif is known to be responsible for signaling,
and it should be possible to link the signaling reaction to the motifs instead of
the molecule. This makes it simpler to represent molecules that have several,
independent motifs.
Since there is a many-to-many relationship between motifs and proteins, we
add a collection of motifs to Molecule. A motif is represented by a Motif entry,
which is a subclass of Molecule to make it possible to use it in signaling cascades.
2.4.5 Family
Grouping molecules and motifs into families is essential for a usable signal trans-
duction database. When the family relationships are stated in a formal way, it
is easy to write algorithms that exploit them in user queries, see 2.5.4, while
marking inherited properties as inferred information.
Family specifically addresses the issues of
1. molecule classification
2. paralogues3
3. orthologues
The family relation is implemented by the groups/members collections men-
tioned in 2.4.2. In the molecule classification, the last classes before the indi-
vidual molecules are groups of paralogues. The same classification is used to
handle the orthologues, grouping them under a species independent group entry.
By overloading this collection we avoid creating yet another hierarchy and can
extend the mechanisms for paralogue handling to orthologues.
Paralogues
Due to gene duplication and mutation within species multiple paralogues have
often evolved. For a single gene, there may in turn exist different splice vari-
ants. Sometimes in the literature a signaling activity is first attributed to a
3Orthologue and paralogue: A pair of genes are orthologous when they are different because
of a speciation event, and are paralogous when the difference resulted from a gene duplication
event.
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Figure 2.4: Adenylate cyclase family tree. Ca-dep. are the calcium dependent
forms, Uninh. are the forms without inhibition mechanism and Gi-inh. are the
forms inhibited by Giα or calcium.
single molecule, and later it is discovered that there is a whole group of similar
molecules.
For example look at adenylate cyclase (AC, Fig. 2.4). There are at least nine
isoforms, ACI–IX), which are all activated by Gsα, while only isoforms I, III and
VIII are Ca/CaM dependent, II, IV and VII have no inhibition mechanism and
V and VI are inhibited by Giα or calcium.[SDG96]
We represent this kind of hierarchy in the database.
Orthologues
In many cases, reactions between proteins have only been shown for one of
several model species, like rat, clawed frog or fruit fly. It is common to scan
sequence databases for orthologue sequences and assume, if these can be found,
that they play a similar role in signal transduction. This orthologous grouping
makes it possible to stitch together pathways from bits and pieces that have
been investigated in different species. We pragmatically add orthologues to the
family tree for paralogues, by grouping them under one of the entries in the
tree, usually at the isoform level.
Classification methods
Since it is easier to examine the sequence of a gene or protein than to investigate
its function, a certain behavior is usually shown in detail for only few members of
a protein family, and homologues are added to the functional group by sequence
or structural similarity.
Based on this assumption, various good databases exist that try to classify
proteins and map sequence motifs to functional annotation [BBD+00, CGK99,
HHP99, HBFB99, Apw00]. They cluster proteins by multiple sequence align-
ments and use common structural motifs, “profile” patterns, or Hidden Markov
Models derived from these alignments to classify new proteins. Sometimes these
methods can predict the function correctly, but sometimes not.4 Thus it is com-
4If the behavior would always be predicted correctly, the automated construction of a
signal transduction database would be feasible: a whole signaling network content could
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mon practice to group molecules into families on the basis of sequence similari-
ties, even if they do not share common behavior.
For a signaling database, it is advantageous to group molecules that show
common signaling behavior, that is, to group them by function. Since it is the
function we are interested in, we would like to group only by function. On the
other hand, we would like to draw as much as possible upon expert knowledge,
and stay coherent with the groupings that already exist. To solve this dilemma,
the best option seems to be that we group the molecules as is done traditionally,
but link signaling only to those molecules for which it has been shown.
Given the tree for adenylate cyclase in Fig. 2.4, if the calmodulin-dependent
reaction has been demonstrated for ACI, we link that reaction to ACI only. We
link statements made on a generalized level, like the ones from review papers,
to nodes on a higher level in the molecule hierarchy. Given the tree, we can for
example link the general Gsα activation to the AC group. The context of the
original literature statement is preserved.
2.4.6 State
The unmodified form of a protein and all its modified forms are its states, where
the modification can be by covalent binding, by complexation, or by change of
environment. The protein per se is a concept that is based on the observation
that there is only one gene coding for each protein sequence. All the states
share the same gene and consequently part of their structure, the amino acid
chain. They are functionally related, often even reversibly transformable into
each other.
A basic Molecule entry captures this concept and is the class of all states of
a protein. These states are different molecules, and we store them as different
Molecule entries. As Molecules, they can be used in a pathway assembly. We
store general information like the amino acid sequence in the basic Molecule
entry and link its states to it.
In the simplest case there are only two states, an inactive one, and an active
one. In other cases, there are more. For example, a transcription factor can be
1. de-phosphorylated in the cytosol
2. phosphorylated in the cytosol or
3. phosphorylated and bound to DNA in the nucleus
to name a few possibilities. The same protein will exhibit distinctly different
signaling functions in these three states. For example in state 1 it will be
susceptible to phosphorylation, in state 2 to translocation into the nucleus or
dephosphorylation and in state 3 it will activate transcription.
The number of states for a molecule is the product of the number of its
modified forms and the number of locations (see 2.4.9) where it is found. Only
compounds which share the same location interact in nature.
It is impractical to enter a separate state for each location. Most molecules
can be found in several tissues, at several development stages, in several cellular
compartments, several organs and several celltypes. To enter a state Molecule
automatically be generated from the sequence databases.
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Figure 2.5: State switching
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Ras Superfamily
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Ras:GTPRas:GDPcomplex
Other States
Figure 2.6: Hierarchical relations and roles for Molecules, shown for a subset of
the Ras superfamily. Basic Molecules are translated proteins or small molecules
that have mass. Family Molecules are groups of related molecules or of other
molecule groups. Motifs are structural or sequence motifs of basic Molecules.
Complexes and other states change the availabiliy of the molecule for reactions.
for each possible combination would lead to an explosion in the number of states,
and redundancy in the reactions. This problem is circumvented by using the
location list inherited from Component.
In each state, the molecule is available only for a subset of all reactions for
that molecule. Receiving a signal changes the molecule’s state, usually leading
to a new state from which reactions are triggered (Fig. 2.5).
When the molecules assembled in a complex show different signaling behav-
ior from the independent molecules, this complex is a state for them. We link
it as such to all its constituent member molecules.
Fig. 2.6 sums up all the various hierarchical relations that Molecules in the
database can have.
2.4.7 Reaction
Reactions as processes are not physical entities like molecules, yet they are the
central point in a signal transduction database. By representing these reactions
between molecules as separate nodes in the graph, it becomes possible to store
their properties and annotate them.
Since many reactions in signal transduction are catalyzed, and most cat-
alyzed reactions are quasi-unidirectional, all reactions stored in the database
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Semantic reaction Mechanistic Reaction
Signal flow Mass flux
Implied states “active” and “in-
active” for the molecules. The
Reaction is linked to basic
molecule entries.
States are explicitly stored in the
database. The Reaction is linked
to state molecule entries.
Emphasise meaning of reaction
for molecules.
Emphasize meaning of molecules
for reaction.
Only two roles for molecules: sig-
nal donors and signal acceptors.
Four roles for molecules: reac-
tants, enzymes, modifiers, and
products.
Easy to read or enter, less detail. Hard to read or enter, more de-
tail.
Useful for extracting review liter-
ature and proven influences with-
out known mechanism.
Useful for extracting primary lit-
erature and interactions with in-
formation about mechanism.
Table 2.1: Semantic and mechanistic reactions in comparison.
are unidirectional. Equilibrium reactions are stored as two reactions, one for
each direction.
There are a semantic and a mechanistic view to reactions in the database.
Both views of the Reaction have their merits and are used. Table 2.1 summarizes
the properties of the two views, which are discussed in detail in the next sections,
and Fig. 2.7 shows the difference graphically.
The basic molecule entry should be used in the semantic reactions. The
states should be used in mechanistic reactions. To avoid a mixing up of concepts,
the basic entry is not used as any of the states. In particular, the basic entry is
not used in place of the unmodified form.
Semantic reactions
The representation of reactions commonly encountered in scientific review pa-
pers can be seen in Fig. 2.8. I call this representation semantic, because it as-
signs a meaning to the states of the molecules for the overall network, “active”
or “inactive”. It is easy to understand and it is familiar to scientists from the
papers. It shows how the signal flows through the network. The reactions need
additional information, namely if they activate or inhibit the target molecule.
The reactions in this scheme are binary. Molecules act as signal donors or
signal acceptors to the reactions.
This view implicitly assumes that each molecule exists in an active and
an inactive state. It is not necessary to differentiate between them, as it is
understood that incoming activating reactions always refer to the inactive state,
while incoming inactivating reactions and outgoing reactions refer to the active
state. Because the states are implied for semantic reactions, we link them to
basic Molecule entries in the database.
Saying that a molecule has an “active” or “inactive” state is a semantic
statement. Both states undergo reactions, and the decision which is which can
consequently only be determined in the larger context of the whole network.
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Figure 2.7: Semantic and mechanistic reactions. Semantic reactions (small,
light squares) go from Ras to Raf and from Raf to MEK, implying that each
of those molecules has two states, one “inactive” for receiving signals, and one
“active” for passing them on. The other Reactions (darker, bigger squares) are
mechanistic and assign states explicitly to the molecules.
Figure 2.8: Typical data from review literature. Putative pathways to NF-κB
activation [SB97]. Arrows are activating reactions. Multiple arrows indicate
multiple steps, question marks uncertainty.
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Figure 2.9: Typical data from the primary literature. The data show that β-
catenin and axin are phosphorylated by GSK3, and presence of axin increases
the phosphorylation of β-catenin. FRATtide inhibits the phosphorylation by
competition [T+99]. Another paper [ABS+97] then shows that the phosphory-
lated form of β-catenin is ubiquitinated and degraded by the proteasome.
Mechanistic reactions
The classical chemical reaction notation
ν1X1 + ν2X2 + . . .+ νnXn
E

 ν′1X1 + ν′2X2 + . . .+ ν′nXn
can model aggregation into a complex, dissociation of a complex, chemical
modification and catalysis in the detail necessary to capture data from the
primary literature. An example for this kind of data is given in Fig. 2.9. I call
this representation mechanistic, because it reflects how the molecules interact,
and not how the signal is transported. It is well-established and familiar.
Molecules act as enzymes, substrates, modulators or products, and any re-
action has exactly one or no enzyme, one or more substrates, any number of
modulators, either inhibitors or activators, and one or more products. There is
semantic information in assigning some of the inputs to the enzyme or modula-
tor collections, which tells us something about the local meaning of the molecule
for the reaction.
This view is more tiring to read and enter, and demands a more detailed
knowledge of the mechanisms of transduction, because it shows in more detail
what happens. It makes no assumptions about the molecule states. All the
different states of a molecule have to be listed as separate entities, and in the
database we link the mechanistic reactions to state Molecule entries.
Translocations
In a translocation, the same molecule enters and leaves the reaction with a
changed spatial context. This process takes some time, which is important for
the dynamic behavior of the network.
Translocations cannot be represented in the basic mechanistic model which
assumes all reaction partners are present in the same reaction space. Since
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a molecule is just associated with a list of locations, we cannot differentiate
between, for example, the cytosolic and the nuclear form of the molecule. A
reaction that moves a molecule from one form to the other is then a loopback
from the molecule to itself. Therefore we either have to associate the two loca-
tions with the Connection entries between the Molecule and the Reaction (see
2.4.8), or subclass Reaction with a class Translocation, which provides two lists
of locations, one for the entering and one for the leaving molecule. The latter
solution is chosen in Transpath.
2.4.8 Connection
Connections are binary relations. They represent directed edges in the graph,
where one end node is always a molecule, the other a reaction. Thus there are
two kinds of Connections, one per direction.
Connections are important because they can contain additional informa-
tion that is dependent on the context between a molecule and a reaction, like
stoichiometric factors or location information. Connections can store kinetic
parameters for reaction modifiers, for example the Ki constant of a competitive
inhibitor, which is dependent on the inhibitor and the reaction.
Connections can help to depict translocation reactions, by associating one
location with the incoming and another location with the outgoing connection
of a reaction.
2.4.9 Location
Location describes spatial and temporal environments. It tells apart molecules
and reactions found in different kinds of cells, tissues and organs. Without it
we would get the model of a super-cell, which can do everything. Imagine the
network for each cell being drawn on an overhead-sheet. Then the view without
location information would be all these sheets layered on top of each other.
Signaling needs the location context. Subcellular location plays an important
role in the activity of many compounds. For example transcription factors like
NF-κB are only active in the nucleus, Ras is only active after recruitment to
the inner plasma membrane. Since all signaling takes place in the complex
matrix that is the multicellular organism, we first need a good model of the
spatio-temporal segmentation of the organism.
Relevant aspects of location include:
1. subcellular location. Examples: nucleus, plasma-membrane associated or
spanning, mitochondrial, cytosol.
2. tissue/cellular location. Examples: liver, kidney, body, glomeruli, Schwann
cells, adipose tissue
3. developmental stage. Example: Carnegie stages in human.
4. species. Example: vertebrata, mammalia, human, rat, mouse
The location items often relate to each other in tree-like schemes. A human
for example is a vertebrate in the taxonomic dimension. Glomeruli are a sub-
structure of the kidney. This classification is necessary to avoid state explosion
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— otherwise we would have to insert a separate entry for each subtype, when
the supertype is mentioned in the literature.
Sequences and molecular weights differ between orthologues. While the
species is categorized as part of the location of a molecule, these orthologues
are not different states of the same molecule, they are different members of a
group of molecules. The molecules from different species are stored as members
of their orthologue group (see 2.4.5).
The experimental proof for an Reaction is usually obtained in artificial sys-
tems. We cannot claim that a reaction takes place in a cell in vivo, simply
because all involved molecules are found in this cell. We have to link the reac-
tion to the location for which it was proven.
When we have further information that depends on the location, we store
this information in the relation between Location and Component.
2.4.10 Hyperlink, Annotate, Reference
These classes are not important to model the biology itself, but they serve to
integrate annotation and other resources with the pathway graph. In short Ref-
erence refers to papers from literature from which the information we present
in the database was extracted. Hyperlinks connect to external databases. An-
notates are user visible comments of all kinds.
2.4.11 Method, Material
Method and Material are used to assign a quality or level of trust to the experi-
mental findings. Method lists experimental methods and Material lists biological
materials used in conducting the experiments. This information is not extracted
from the literature. It is provided as an additional service to the user.
The quality level can be used by the pathway builder for automated high-
lighting or to filter out low-trust data.
2.4.12 Signal
A signal according to Webster is:
(. . . ) a: an object used to transmit or convey information (. . . ) c:
a detectable physical quantity or impulse (as a voltage, current, or
magnetic field strength) by which messages or information can be
transmitted
In signal transduction a diverse set of molecules interacts with each other.
The signal cannot be a physical part of any of these, such as a phosphate group,
since these items stay localized with their carriers, while the signal travels on.
So definition a is not useful.
Using definition c, the only physical5 quantity that all the signaling molecules
share and that changes as the signal proceeds is their concentration. It would
be chemically correct to speak of their activity. The activity inside the cell is
hard to determine, so for our purposes concentration has to be good enough.
5Actually chemical.
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If we express the signal as the change in concentration of activated tar-
get divided by the change in concentration of signal source [KHWB97] we can
quantify the signal transfer. Shannon entropy, a concept of information theory,
gives the classical way to measure signal transfer, but is not so easily applicable
here.[SW63]
Input signal and reaction strength determine the output signal. We find
analogues for them in signaling molecule concentrations and rate constants.
Signals travel through the network. They are not static and for this reason
are not stored in the database. Consequently Signal is not implemented as a
class.
2.4.13 Pathway
Pathways are not explicitly stored in the database. They can be dynamically
created from the underlying graph upon request. The graph incorporates all the
available and atomically updatable data and allows to please differing opinions
on where pathways should be bounded.
Pathways in the current implementation can be generated with the pathway
builder, see 2.5.4.
2.5 Interface for the Transpath database
The interface for the database is implemented as a web interface for access over
the World Wide Web. It is written using the Java programming language.
The web interface uses a 3-tiered architecture, with the computational logic
in the middle tier on the server side. Fig. 2.10 shows the general layout. Server
side logic has the advantage that it has direct access to the data in the database,
which is faster then sending requests over the net.
Requests are sent by the browser and accepted by the web server, which
channels them to one of the servlets. The servlets themselves are wrappers
that either translate the parameters of the request into calls to internal APIs or
handle simple requests themselves. All servlets that need to access the database
are isolated from the actual database vendor implementation by the Clerk class.
The Clerk finally forwards requests to the database server. The database server
returns the data in the form of objects which are formatted into HTML pages
by the servlets and returned through the web server to the browser.
Some servlets, like the TemplateServlet or the SetServlet do not need to
access the database for their work. TemplateServlet is used for the generation
of a few templates like HTML pages and SetServlet is responsible for managing
transient result set data.
2.5.1 Sessions
HTTP is a stateless protocol yet there is information that we have to store
about a user’s session:
Several databases are offered through the same interface. We have to re-
member with which of those any one user is accessing.
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Web Server
DatabaseBrowser Servlet
SetServlet
GraphServlet
OQLServlet
StoreManager
Store
StoreServlet
Request
RequestServlet RequestViewer
XtalkServlet
Transfac/Transpath Unified Client
GetServlet
Graph
Search
Query
Clerk
DBIT database integration tool
TemplateServlet
Figure 2.10: Schematic interface for the database. The light boxes at the bot-
tom are command-line tools for the same tasks that the web interface servlets
provide, a stand-alone input client application[Gro00] and an export tool to
relational databases[Chr00].
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Entering new data (see 2.5.2 below) is a privileged activity and needs forms
instead of the normal view which merely displays the data. We have to
remember which mode the user is in.
Classified information may be accessible only for certain users. We let users
log in and have to remember their authorization level.
Result sets generated by requests are open for subqueries and usable as mod-
ules for pathway queries. We have to remember and manage the result
sets for any one user.
Other formats for output that the user has elected have to be remembered.
To address these issues, the web interface remembers the state of a connec-
tion by a browser. It does so by using a session id, which is issued by the servlet
upon the first request and sent by the client with subsequent requests. This
allows storage of information about the connection on the server under this id,
and saves sending it back to the client with every response, which would be
prohibitive for things like large result sets.
Since not all browsers support cookies, the session id is appended to all
URLs as a parameter. Enforcement of cookies would be an easier solution, less
susceptible to the user using his BACK button until reaching a page where he
had no session id and thereby losing his session context.
All Servlets have to be programmed in a thread-safe way, once internal state
is retained. Otherwise, if a servlet is working on the request of a user and the
same servlet instance is called by a second user who has chosen different param-
eters, the servlet’s internal state will change also in respect to the first user, and
the results are out of control. To avoid doing the locking and synchronisation
for shared internal state variables explicitly we are careful to not store state in
the servlets themselves, only in the session context.
2.5.2 Data entry with a form client
Data entry to the Transpath database is done based on XML flatfiles, which
are parsed into objects and submitted to the database. This approach allows
low-tech support for external updaters, which can use a local application or a
plain text editor to create the files. The files then can be sent in via e-mail, and
parsed into the database. The SWISS-PROT database for proteins [BA00] has
operated on a similar model for several years.
For our database this approach is difficult. The data is highly interconnected,
and practical experience has shown that annotators need to query and visualize
the incremental updates they make while building the network. A dedicated,
web-independent input client application, which also interfaces to the TRANS-
FAC database [W+00] was developed independently of this work to integrate
the two resources [Gro00]. Due to technical difficulties, this tool unfortunately
proved too slow to allow sensible work.
The input client that is used for daily data input is based on the web interface
and automatically generated forms. The forms are produced dynamically and
reflect the fields that are available in the entry type. When adding new fields,
nothing has to be changed in the input client code as it adapts automatically.
Upon submission the forms are transformed into XML text and then parsed
into the database by the StoreServlet.
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nfkb.jpg (562x523x16M jpeg)
Figure 2.11: An example clickable map. This is an especially good example,
since it shows not only the advantage of maps for visualisation, in being optically
pleasing, but also the disadvantage, because this map is missing MyD88 at the
IL-1R complex, which was more recently discovered and not entered when the
map was created.
2.5.3 Web navigation interface
The user has the top level options to
1. Browse the database by using preconstructed clickable pathway maps, like
the one in Fig. 2.11.
2. Query the database in the classic, text-match based way, either with a
simplified query form, or with a full OQL query.
3. Pose pathway and crosstalk queries about entries identified by accession
number.
Most users start by browsing the maps and clicking on an item or by looking
for a Molecule of interest and choosing from the resulting list. In both cases,
they end up with a single molecule entry, like the one in Fig. 2.12. From there
they can either follow the Hyperlinks to connected entries, or enter pathway
queries.
Users interested in automated analysis of the data can choose other formats
than HTML, which are easier to parse, like a simple text flatfile format or XML.
They can download the whole contents of the latest database release in XML
format, if they desire to do so.
2.5.4 Graphical Pathway Builder
The pathway builder executes pathway queries and outputs the results. The
default visualisation is a pathway cascade, and a second option is an automated
layout by graph drawing tools.
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Figure 2.12: Example output for a single molecule entry. In this example, the
option to show family information was selected, printing above it abstracts of
families to which this molecule belongs.
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Figure 2.13: An example network. Squares are reactions, circles are molecules,
dark dashed arrows are catalytic influences, solid arrows are mass fluxes and
light dashed arrows are family relationships, where the superfamily is at the
end which has the arrowhead. In graph terminology, the arrows are called
directed edges, and the squares and circles are called nodes. The same notation
will be used in the following figures.
The cascades produced by the builder are mistaken by some users as pre-
dictions of signaling behavior, but this is not the case. Pathway queries merely
return subsets of stored data and then visualize them in a sensible manner.
These visualisations do not constitute actual predictions of what happens in
the cell, and therefore can show reaction sequences which will not normally
happen. Simulatory predictions, which are covered in 3.2, need the assignment
of dynamically changing activities to the molecule nodes.
Fig. 2.13 shows an example network used here to explain the behavior of
the pathway builder in detail. The examples were generated with a small test
database containing this network. The same procedures are of course applicable
to the larger database which contains the actual biological knowledge. The
figure shows that the pathway builder treats reactants, enzymes and modifiers
as inputs and products as outputs. To find out the exact role of an input, the
user currently has to look at the full reaction entry.
Note that the way the reactions and molecules are depicted to be wired
here is a reaction-centric view. Reactants and enzymes lead into a reaction,
while products are emitted from the reaction. In the database there exists an
additional edge for each edge in the figure, which goes in the exactly opposing
direction. If we say that we follow an edge against its direction, then we actually
follow that backlinking edge. This technical detail is not needed to understand
the behavior and is mentioned here only for correctness.
So, let us forget about inheritance and protein families. The central part
of the image is on one hierarchy level, and staying on this level we can set a
direction and a distance for the search. If the direction is
downstream, the builder follows the edges along the direction in which they
are pointing.
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upstream, the builder follows the edges against the direction in which they
are pointing.
up- and downstream, the builder follows the edges of the starting node in
both directions, so that both these trees are constructed.
reachable, the builder follows the edges in both directions at any node, so that
the whole connected net around the starting node is traversed.
Fig. 2.14 shows the traversal in up and down direction. In downstream
direction with respect to node C, node F can be reached by two paths, and
the search skips it the second time around. This is necessary, since otherwise
feedback cycles – imagine reaction 3 pointing back to C instead of F – would
make the search run forever. That the node F has been observed before is
shown in the output by setting its name in brackets. The bracketed hyperlink
does not point into the database, but points to the point where the node, and
consequently possible subtrees, appeared first. This makes it easier to follow the
flow of the cascade. All other names are hyperlinked to retrieve the respective
single entries from the database.
An important point here is that nodes D and Y are not seen in the upstream
and downstream traversal, even though they are part of traversed reactions and
are thereby connected to the starting node. The edges connecting them do
not have the right direction to be considered by the search. This again shows
that the output cascade is a way to show data, not to predict what happens
biologically: reaction 1 would probably not proceed in the absence of its enzyme.
The right side of Fig. 2.14 shows the concept of search distance. The search
distance is the number of edges that will be traversed away from the source
node, before the search skips further subtrees. Since node F would be at a
distance of six following the path from A over C and E, in the example with
distance set to four, the search stops following this path before reaching node
F. On the path over C to F directly, which is the shortest path but is traversed
later in the normal search6 F is within the distance of four and is shown in the
output.
The search distance limit is useful, as the output tends to get too long to be
useful without it. If the user wishes he can switch it off by setting it to “any”.
Fig. 2.15 shows the traversal with the “reachable” option. The output uses
another symbol for the reactions to make clear that no direction is shown. If the
distance were greater than two, we would observe a lot of bracketed instances of
the three already traversed reactions in the output, since they can be reached
again from the current leaf molecules, by following the edge that led to those
molecules in the backward direction.
Searching for the whole connected net generates unwieldy outputs even for
small distance limits. It still is a useful option, if the aim is to extract the
whole subgraph that is connected to a node, for example for further analysis,
or visualisation by other tools.
6The order of traversal in the depth-first algorithm employed for the normal search depends
on the order in which neighboring nodes for the current node are listed. Since we do not
guarantee any order for the collections in our class definition, we can not rely on having a
certain order. That the shortest path is found later here is coincidental, but the larger the
number of possible paths gets, the more likely we are to traverse a longer path first.
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Figure 2.14: Search direction and distance. Notation is the same as in Fig. 2.13.
Left side: starting from node C, the upper half shows the traversal in upstream
direction, the lower half in downstream direction. Next to the network the
output produced by the pathway builder is shown. In this output, underlined
text provides hyperlinks for molecules. Clicking it retrieves the Molecule record
from the database. Bracketed, italicized text provides hyperlinks for molecules
that have been seen before in the output. Clicking it jumps to the line where the
molecule was encountered first, is hyperlinked to the database entry and may
have further sub-pathways. Dashed line indicates limiting the search because
of a previously seen node. Right side: starting from node A, a traversal with
distance 2 is shown as a solid line, another one with distance 4 is shown with a
dashed line. The numbers in the dashed boxes are the distances of the nodes in
the box from node A.
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Figure 2.15: The subnet for the reachable direction with a maximum distance of
two. Thick light dashed lines show where the search skipped because the node
was seen before (around the starting node, C), thin dashed lines show where
the distance limited the search.
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Figure 2.16: Graph layout for the test network.
By selecting another output format, the pathway query result can be trans-
formed into a graph layout. Fig. 2.16 shows the result of such a transformation
for our example network. Here the loop between C, E and F can be seen, and
the general structure of our net is directly evident. In cases with more nodes,
the name labels start to overlap and quickly become unreadable.
Tools like Otter [Huf00] alternatively allow us to show the name and addi-
tional information about a node by moving the mouse pointer over it, and they
allow zooming in on regions of interest or picking other start nodes as centers
for the layout. They can color nodes and edges based on their attributes. For
example, molecule and reactions are assigned different colors here.
To show some examples from the actual database, Fig. 2.17 shows the envi-
ronment around the Ras molecule for a distance of four and of eight. One can
easily recognize the smaller environment in the larger one. In the interactive
tool, one can make out important players associated with Ras directly, as they
are linked to a large number of nodes: in both networks, more easily made out
in the smaller one, the half circle to the right above Ras centers on Raf, the
large one to the right below Ras on PI3K, and the one to the left below Ras on
Grb2. In the larger network, the half-circle to the far left centers on p38, and
the largest one, in the middle below, on NF-κB.
Inheritance
The user constructing pathways should be able to set the pathway query pa-
rameters to include subclasses and states, so that he will find a reaction even if
he starts the search at a family or basic molecule that has no reaction linked to
it. The same holds true for including superclasses, and finding reactions linked
to them.
If Molecule entries in the database act as classes, we should think about
inheritance of properties. Supporting inheritance means that the query and
display mechanisms for the database have to find inherited properties and im-
plement overriding. This behavior is similar to programming language classes,
where subclasses can override behavior of their superclasses (see 1.3). As dis-
cussed in 4.2.4 we treat a Family entry in the database like a class, and its
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Figure 2.17: Graph layout for the network around Ras, with distances of four
and eight steps, respectively. Ras is the element in the center of a circle of
surrounding nodes in both images.
reactions and states represent its behavior. The analogy demands that our path-
way engine suppresses the reactions or states of the superclasses when there are
reactions or states for a subclass, and inherits them when there are none.
For example, suppose the general AC entry from Fig. 2.4 is linked to a
reaction which states it is activated by Gsα, and the calmodulin-dependent
subtype ACI is linked to a reaction which states it is activated by Gsα in presence
of calmodulin. Without overriding, ACI inherits the calmodulin-independent
activation reaction in addition to the calmodulin-dependent activation — which
is wrong.
The current implementation of the pathway builder does not support inher-
itance. Instead it explicitly shows to which entry reactions are linked.
By analogy to the search direction and distance, to include family relation-
ships we can set a range and a depth for the search. If the range includes
superclasses, the builder follows the family edges along the direction in which
they are pointing.
subclasses, the builder follows the family edges against the direction in which
they are pointing.
super- and subclasses, the builder follows the family edges in both directions
at any node, so that the whole connected family net around the starting
node is traversed, similar to the reachable option.
Super- and subclasses are evaluated at any node only after all other pathways
branching off in upstream or downstream directions have been exhausted. The
depth works for the range as the distance does for the direction.
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Figure 2.18: Traversal for the test
network with super and subclasses,
depth 2, downstream of C, any dis-
tance.
Figure 2.19: Pathway for the test net-
work with super- and subclasses, as cas-
cade and as list of shortest paths.
Fig. 2.18 shows the cascade that is generated for the test network with both
super- and subclasses included. The pathway builder shows family transitions
by coloring the background depending on the depth from the original level. The
figure on the far right shows the list of the shortest paths to each node in the
cascade, which the pathway builder can generate as an alternative view.
Filtering and Bounding
The pathway builder works by traversing the graph. The search engine by itself
does not execute traversal-unrelated actions upon hitting a node. To restrict
the traversal or define other actions to be executed on the node, listeners7 can
register for the search. The listeners form a pipeline: whenever a node is hit,
an event is dispached to the first listener. The listener evaluates the event, may
add a message for the following listeners to it, and passes it on. Each listener
also can send callback messages to the search engine to make it skip a subtree or
to stop the search. This design pattern is flexible and allows us to plug together
a search from modules.
An additional set of listeners is called after the search has finished. This
allows actions which are based on all the information seen during the search.
There are three classes of listeners that have been implemented:
1. Boundaries limit the search at nodes based on their internal criteria. For
example, restricting the traversal to a certain distance is done by a listener
which knows the distance limit and sends a signal to skip when the distance
of the current node is larger.
2. Filter listeners select nodes based on their internal criteria. They are used
to highlight interesting parts of the output. For example a filter listener
can be used to highlight all transcription factors in the pathway.
7Listener is a technical term from the design pattern [GHuJV86] community. It means a
piece of code that can be registered with another piece of code, to be called back when certain
conditions in that other code occur.
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3. Print listeners use Formaters to transform the nodes into some kind of out-
put format for visualisation. For example, a print listener is used to pro-
duce the graphical cascades, another one transforms the pathway into an
input file for the graph layout engine, and a third one transforms crosstalks
found between two pathways into the format for AliBaba2 [Gra00], a tool
that finds transcription factor binding sites in promotor sequences.8
Result set management
Filters and boundaries both select nodes. Therefore, any listener that selects
nodes can be used either as a filter or as a boundary. A general solution to the
selection problem is to explicitly enumerate the set of nodes we want to select.
This is supported by the interface, which allows storage of any result set of a
query or pathway query.
There can be specialized listeners for cases where the POET implementation
of OQL is not expressive enough to generate the sets. For example a listener that
selects nodes with a minimum number of connections has been implemented.
The set manager supports new queries within result sets to allow iterative
focussing on the entries of interest. A set can be edited, for example added to
an already existing set, so that the new set is the union of the two original sets.
Those sets then can be used as selectors in new pathway queries. For ex-
ample, one could select all molecules and reactions located in rat and limit the
search to this set, or exclude this set from the search.
2.5.5 Flatfile generation
Flatfile generation makes use of a Formater interface for printing the entries
that result from an OQL query or from the result storage. There is one imple-
mentation of the interface per output format. It is possible to output the results
of the web interface query directly into a file, currently as HTML, XML, plain
text, Odf data for graph display, and AliBaba2.
2.5.6 Parsers and data import
The import of data from flatfiles is implemented with input file specific parsers,
which offer a common Flatfile interface to the database. The XML parser is
the default parser for the database. Fig. 2.20 shows an overview of the library
for parsing the data. The web interfaces or commandline-tools and applications
are front ends to this library.
10.073 Molecules in the Transpath database are imported from SWISS-
PROT public Release 36. The high number results from inclusion of several
vertebrate species. Records in the input file are translated into sets of objects
referring to each other. For example, a typical SWISS-PROT entry is translated
into a Molecule, several Hyperlinks, several Locations, several Annotates and
several References.
In object oriented databases objects point directly to each other. A two-pass
strategy is employed to import sets of related objects. In the first pass over the
input file, entries without linking information are created in the database. In a
8The idea here is to see if co-binding factors are co-regulated.
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Figure 2.20: UML layout of the parser package.
second pass, the entries referring to each other in the input file are linked in the
database.
Every imported object is uniquely identified by storing its source database
and accession number in a “external identifier” field for its imported entries.
The contents of the CSNDB [TIK00] database on signal transduction are
available in a separate database instance, which can be selected as an alternative
data source under the Transpath interface.
CSNDB uses a public DBMS called Acedb[DM91], which allows storage of
user-defined complex data types. The layout of these types is defined in a
“model” file, which also declares name tags for the property slots. The data are
distributed as a flatfile marked with those tags.
The class layout of CSNDB as well as that of Transpath changes over time,
as improvements are realized. To decouple the class layouts from each other,
a ModelReader uses a file with mapping rules to produce Model objects, one
object per CSNDB class. The Model objects describe how every property of
the CSNDB-class is translated in the Transpath schema. If either class layout
changes, only the map file has to be updated.
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Chapter 3
APPLICATIONS
Hardware lives for a few years, software lives for many years, but the data lives
forever. The value of any database lies in the stored data. The presentation
and storage systems for this data may change, but the data is there to stay.
The human mind can hold about seven pieces of information and their rela-
tionship at any one time [Voi00]. Valuable information is often hidden in large
amounts of collected data and computers have to be employed to extract it.
Data Mining [WF99] is a whole research discipline concerned with finding in-
teresting patterns in data and clustering data into groups for apprehension by
the human mind.
A good example are the DNA sequence databases. The human genome se-
quence holds most of the information that is necessary to create human life,
yet by looking at it with the unaided eye, we understand nothing. In the wake
of the accumulation of DNA sequence data, a host of algorithms has therefore
been developed to aid in analysing and handling this data. Gene-finding soft-
ware separates coding regions from untranscribed regions. Sequence alignment
software like BLAST [AMS+97] makes it possible to find similar sequences and
quantify their similarity. Evolutionary trees are constructed from such similarity
calculations.
Signal transduction data can likewise be used as input for algorithms. Better
descriptive overviews, analyses or even simulations are imaginable. The devel-
opment of suitable algorithms provides many challenges for research. As first
steps in this direction, three simple applications based upon the kind of data
stored in Transpath have been devloped.
The first of these applications is an examination of the static connectivity of
the network, the other two are dynamic simulations using models of signaling
pathways.
3.1 Path alignments
A signal transduction pathway for our purposes in this section encompasses the
molecular interactions triggered by one or more extracellular signaling molecules
that lead to the activation of one or more transcription factors.
One of the questions regarding such pathways is: where is the specificity
achieved?
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Path alignments are employed here to suggest a possible answer. The idea
behind path alignments is simple: we reduce the pathway network to sequences
of molecules. Then we use sequence analysis tools to explore the relationships
between these sequences.
3.1.1 Paths
For the following discussion we again represent the signal transduction network
as a directed bipartite graph, where the nodes are the network’s molecular
species and reactions as described in 2.4.2. The molecule nodes are labeled
according to their class. In particular, we have among them a set consisting of
extracellular signaling molecules Si and a set of transcription factors Tj .
Instead of dealing with whole pathways directly, we split them into bundles
of linear paths. Properties of the pathway that rely upon the integration of two
or more input signals or on feedback effects are thus lost in the new form. We
define
Definition 1 (Signal transduction path) A signal transduction path is the
cycle-free series of edges and nodes leading from a molecule node labeled as
extracellular signal to a molecule node labeled as transcription factor.
Such a path is linear and can be represented as a string of nodes. Consider
for example the simple network in Fig. 3.1: In this network there are three
paths. When we skip the reaction nodes, which for our purposes do not carry
additional information, we can write them as P1 : S1/A/B/T1, P2 : S2/H/I/T2,
and P3 : S1/H/I/X/B/T2. The slashes serve as delimiters of the node names.
B
A
X I
H
T1 T2
S1 S2
P1 P2P3
Figure 3.1: Short arrows represent reactions, S1 and S2 extracellular signaling
molecules, T1 and T2 transcripton factors, A, B, H, I, and X intermediary
molecules. P1, P2 and P3 are paths.
3.1.2 Assumptions
We assume that the shortest path between an extracellular signaling molecule
and a transcription factor is the most efficient and biologically relevant path, as
it is wasteful and more error prone to use a longer path.
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3.1.3 Method
Based on this assumption we filter out the shortest paths between all possible
pairs (Si, Tj) present in the database, by performing a breadth-first search for
each Si and retaining all paths that lead to one of the Tj . Each of these paths
may share part of its sequence with other paths. In our example the path P3
does this with P1 and P2.
Since paths are sequences of symbols, we treat them in the same way as we
treat nucleotide or protein sequences, and we use alignment tools to compare
them. We also use the similarity scores generated by such alignments to cluster
them into hierarchical trees, where similar sequences show up in neighboring
leaves.
The difference between path and polymer sequences is that for paths we
have to deal with an alphabet of thousands of different symbols, whereas for
polymer sequences there are only four different nucleotides or twenty amino
acids. Common bioinformatics alignment tools like ClustalW [THG94] cannot
be used for our purposes as they exploit the limited number of letters in these
alphabets to be more efficient. ClustalG [WH99], originally developed for event
series analysis in psychology, is a general alignment tool which does not have
these limitations.
When matching two nodes against each other, the simplest comparison
regime is an identity test. A score of one is assigned if both nodes are identical,
otherwise zero is assigned . Ideally, we should reflect similar signaling behavior
between members of a protein family by assigning a positive similarity score to
a match between two family members.
ClustalG presently does not support similarity matrices. Therefore we use
the identity test.
Generating the paths
A breadth first variant of the graph traversal algorithm allows listeners to reg-
ister and track the shortest paths. Listeners exist for hyperlinked HTML, plain
text and the FASTA format employed by the ClustalG alignment tool. The
plain text output for the path from acetylcholine to NF-κB looks like this:
acetylcholine/muscarinic acetylcholine receptor/Gi/adenylyl
cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein
kinase C/NF-kB: 10
The number at the end designates the number of steps. Slashes are used
instead of hyphens to avoid ambiguity with hyphens in molecule names. For
more detail into where the family transitions occur, it is possible to print the
reactions, too.
The FASTA input format for ClustalG consists of a name for the sequence
and a five letter string for each letter in the alphabet. We use the ends of the
sequence, the extracellular signaling molecule and the transcription factor, to
name the sequence. This name is unique since only one shortest path between
the two nodes will be found. We convert the entry accession numbers to base
26 to get letters, and the above path looks like this (all generated paths can be
found in in Appendix C):
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>acetylcholine@NF-kB—10
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3.1.4 Results
We use the whole CSNDB-dataset to create all possible shortest paths, exept
for the nuclear receptors. In the case of the nuclear receptors, the path only
consists of the two end nodes and an alignment does not make sense. The full
alignment is included in Appendix C. Clustering the alignments and visualizing
the distance tree in TreeView[Pag96] produces figure 3.2.
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IL-3@Jun|8
IL-3@AP-1|9
IL-2@NF-kB|7
adrenaline@CREB|7
IL-2@NF-AT|7
adrenaline@CREB1|7
adrenaline@c-Fos|7
IL-2@Elk-1|11
IL-2@p21|8
adrenaline@CREB2|7
IL-2@CREB2|7
IL-2@c-Fos|7
IL-2@c-Myc|8
acetylcholine@CREB|7
IL-2@STAT5|3
acetylcholine@CREB1|7
acetylcholine@CREB2|7
IL-2@AP-1|11
IL-2@Jun|10
PDGF@NF-AT|8
IL-3@NF-AT|7
serotonin@CREB2|6
serotonin@c-Fos|6
IL-3@NF-kB|7
PDGF@NF-kB|8
adenosine@CREB1|6
adenosine@CREB|6
NGF@Jun|7
NGF@AP-1|8
ACTH@NF-AT|11
CRH@NF-AT|12
GH-RH@NF-AT|11
adenosine@NF-AT|10
NGF@NF-kB|7
acetylcholine@NF-kB|10
acetylcholine@AP-1|11
acetylcholine@Jun|10
adrenaline@NF-kB|10
adrenaline@AP-1|11
adrenaline@Jun|10
adenosine@NF-kB|9
adenosine@AP-1|10
adenosine@Jun|9
ACTH@NF-kB|10
CRH@NF-kB|11
CRH@Jun|11
ACTH@Jun|10
ACTH@AP-1|11
CRH@AP-1|12
ACTH@Elk-1|13
CRH@Elk-1|14
GH-RH@Elk-1|13
adenosine@Elk-1|12
GH-RH@NF-kB|10
GH-RH@AP-1|11
GH-RH@Jun|10
EGF@c-Fos|5
NGF@Elk-1|7
EGF@CREB2|5
IL-3@c-Myc|4
adenosine@c-Fos|6
PDGF@c-Myc|5
adenosine@CREB2|6
IL-4@STAT6|3
IL-9@c-Myc|6
IL-9@NF-AT|9
IL-9@STAT3|3
IL-9@NF-kB|9
IL-9@p21|7
IL-9@Elk-1|10
IL-9@AP-1|11
IL-9@Jun|10
acetylcholine@c-Fos|3
IL-10@c-Myc|6
IL-10@NF-AT|9
IL-10@STAT3|3
IL-10@NF-kB|9
IL-10@p21|7
IL-10@Elk-1|10
IL-10@AP-1|11
IL-10@Jun|10
IL-12@STAT4|3
serotonin@NF-kB|6
serotonin@Elk-1|9
serotonin@AP-1|7
serotonin@Jun|6
serotonin@NF-AT|9
serotonin@p21|7
serotonin@c-Myc|9
TNF-alpha precursor @NF-kB|5
L-glutamate@CREB|4
TNF-alpha precursor @NF-AT|6
NRG-2@CREB|4
prostaglandin D2@PPAR-gamma|3
PDGF@CREB|6
TNF-alpha@NF-kB|4
IL-1@NF-kB|7
TNF-alpha@NF-AT|5
IL-10@STAT1|3
acetylcholine@Elk-1|11
adrenaline@Elk-1|11
acetylcholine@NF-AT|10
adrenaline@NF-AT|10
acetylcholine@p21|8
acetylcholine@c-Myc|10
adrenaline@p21|8
adrenaline@c-Myc|10
ACTH@c-Myc|15
CRH@c-Myc|16
ACTH@p21|13
CRH@p21|14
adenosine@c-Myc|14
adenosine@p21|12
GH-RH@c-Myc|15
GH-RH@p21|13
GH-RH@CREB1|7
EGF@NF-kB|9
EGF@Elk-1|9
GH-RH@CREB2|7
EGF@p21|6
serotonin@CREB|6
EGF@c-Myc|8
serotonin@CREB1|6
EGF@NF-AT|8
IL-3@p21|5
GH-RH@CREB|7
PDGF@p21|6
GH-RH@c-Fos|7
PDGF@AP-1|10
PDGF@Jun|9
PDGF@Elk-1|9
ACTH@c-Fos|7
CRH@c-Fos|8
CRH@CREB2|8
ACTH@CREB2|7
EGF@AP-1|10
EGF@Jun|9
CRH@CREB1|8
IL-3@Elk-1|8
ACTH@CREB1|7
ACTH@CREB|7
CRH@CREB|8
Figure 3.2: Distance tree for all paths in CSNDB.
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3.2 Qualitative simulation with Boolean Networks
Facing sparse kinetic data, from the several possible methods to simulate net-
work behavior, Boolean networks and Petri nets were chosen for investigation.
Boolean networks are simple and modest in data needs, and Petri nets seem
promising because they support different levels of detail. This section deals
with the results of a simplified Boolean network for the MAP kinase cascade,
and the next section will present a more elaborate model for the same cascade
using Petri nets.
3.2.1 Boolean networks
Boolean networks [Kau93] are directed graphs, they consist of one node type
connected by directed edges. The wiring corresponds to the edges in the graph.
A single node has one or more input nodes, and can serve as an input to any
number of target nodes. In the context of a single node, wiring refers to the
edges coming from the inputs. Each node can be in one of two states, either
“on” or “off”. Usually on is numerically represented as a 1 and off as a 0. A
rule table maps input states to a new node state. For a node with k incoming
edges, the ruletable thus has 2k entries, and the rule as many bits. The sum of
all node states is the system state.
Starting from an initial distribution of on/off states, all nodes are evaluated
and are updated synchronously, leading to a new system state. This step is
repeated until a single final state or a cycle of repeating states is reached. Several
starting conditions can lead to the same final state or cycle, which is the reason
for calling these final states basins of attraction.
3.2.2 Modeling assumptions
Boolean networks can represent semantic or mechanistic reaction networks. As
an example we model a semantic network, because in this kind of network each
molecular species can be in only one of two states, either active or inactive,
which corresponds naturally to the two states for a node in a Boolean network.
The semantic information in the reactions can be captured in the wiring and
the rule table.
We translate each molecule species into a node. The activation profile for
each molecule species is assumed to be discrete: if the node is off, the species
is fully in the inactive state: if the node is on, the species is fully in the active
state. Intermediate levels are not supported.
We translate each reaction into edges and changes in the ruletable of the
associated target nodes. If a reaction has several signal donors or acceptors, it
would be a hyperedge in the graph, and is decomposed into several edges. If it
only has one donor and one acceptor, it directly translates to a single edge in
the graph.
The ruletable for each of the acceptor or target nodes is composed from the
rules for each of the incoming decomposed reactions, according to the following
scheme:
Any reaction is then exactly enabled, when all input nodes on the corre-
sponding edges are on. In our example model, each reaction has only one
corresponding edge and is enabled if this edge’s input node is on. An enabled
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activating reaction tries to switch on the target node in the next step, while an
enabled inhibiting reaction tries to switch it off.
If activating and an inhibiting reactions compete for the same target and in a
Boolean network, only one of them can win. We assume that the inhibiting one
wins. Extending this notion to several activating and inhibiting reactions, the
target is switched on only if there are more activating reactions than inhibiting
ones.
3.2.3 Modeling procedure and parameters
Fig. 3.3 shows the layout of the network. The network demonstrates the canon-
ical transcription activation pathway for the Ras-MAP kinase cascade after
stimulation with EGF. It notably contains one positive feedback cycle, leading
to the reactivation of PKC, and one inhibitory interaction by MKP. It does not
contain any of the mechanisms to switch off the original signal that are present
in the cell. Neither does it contain downstream effects and gene regulatory net-
works of the activated transcription factors, which would warrant a model of
their own.
This network was stored in the database and automatically converted into
input files for DDLab, a software for the analysis of Boolean networks (see
Appendix A), a process that can be applied to any subnet of the database.
Nodes without inputs are automatically wired back to themselves and so retain
their state during the whole simulation. This is the case for EGF in our example,
which of course does not have a self-activating reaction in the database.
The central dynamical simulation assumes all molecular species except for
EGF, the signal of interest, to be inactive at the beginning. After we run the
simulation, we can follow the cascade of activation events downstream of EGF.
3.2.4 Results
Fig. 3.4 shows the results of the analysis. Since the network is small, it is
possible to enumerate all 214 possible network states and achieve an exhaustive,
static result for all possible outcomes. Larger networks, which are sufficient
for practical problem sizes, restrict us to define starting conditions and then
simulate until a basin of attraction is reached, as discussed above. There are
statistical methods to estimate the number of basins and other properties even
for these larger networks.
Here we have four basins of attraction, three resulting in a steady state and
one resulting in an oscillatory cycle.
The first basin (upper left) is trivial, consisting of an empty network plus the
combinations of MKP, the MAP kinase cascade and the Transcription Factors
which lead directly to an empty network, empty meaning all species are in the
“off” state.
The second basin (upper right) shows a weak activation of the feedback cycle,
which persists even in absence of the original EGF signal, oscillating between on
and off for all its members. The oscillation is caused by the inhibitory effects of
MKP. Table 3.1 lists the states of all components during the four-step oscillatory
cycle.
The third basin shows strong activation of the feedback cycle, again in ab-
sence of an external signal from EGF. Here the combined activating effects of
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PKC
IP3
DAGCa
EGFR
PLCγ SHC•Grb2•SoS
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MKP
MAP
kinase
cascade
Transcription Factors
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Figure 3.3: Block layout of the Ras–MAP kinase cascade. Pointed arrows:
activation. Arrow with round end between MAP kinase cascade and MKP
inhibition. The numbers correspond to the index of the node.
3.2. QUALITATIVE SIMULATION WITH BOOLEAN NETWORKS 51
Figure 3.4: Attractor basins for the Ras-MAPK cascade. Each dot or circle
is one of all possible states of the system. Circles on the outside are so-called
“garden-of-eden-states” which can not be reached from any other state. Circles
in the center represent the basin of attraction, and are labeled with a bit pattern
representing the on/off states of all nodes. This pattern is broken up into
sucessive rows, starting with the highest node index (13) in the upper left corner,
and ending with the lowest node index (0) in the lower right corner. Successive
system states are connected by lines. Overlaps of these lines are an artifact of
the graphical representation and do not mean these states are connected. Also,
the different hues of these lines only serve to make the grouping more clear
and have no further meaning. The attractor basins are a static representation
of the system change over time. From any state, a timestep leads the system
to the next state, which is placed nearer towards the center of the basin and
inidicated by the connecting line. Finally, when the center is reached, states
proceed clockwise from one to another or a single state is repeated ad infinitum.
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State Nr.
Index Name 1 2 3 4
0 MAPK cascade • •
1 PLA2 • •
2 AA • •
3 PKC • •
4 Ras • •
5 SHC/Grb2/SoS
6 EGF
7 EGFR
8 PLCγ
9 IP3
10 DAG
11 Ca
12 MKP • •
13 Transcription Factor • •
Table 3.1: Active states during the oscillatory cycle. The first state corresponds
to the right hand bit pattern in Fig. 3.4. It leads to the second (lower bit
pattern), which leads to the third (left hand bit pattern), which in turn leads to
the fourth state (top bit pattern). The fourth state leads back to the first one.
• corresponds to “on”.
PKC and Ras are stronger than the inhibiting effect from MKP.
The final basin (lower right) corresponds to all networks states where EGF
is active. Since there is no mechanism in the model to switch off the EGF
activation, any state where EGF is active will lead to full activation of whole
network, including the feedback cycle. This basin contains the case mentioned
above, activation of the network by EGF.
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3.3 Quantitative simulation with Petri Nets
3.3.1 Petri nets
Basic Petri nets are bipartite, directed graphs. One node type, the place, repre-
sents an object in the net and can hold an integer number ofmarkings. The other
node type, the transition represents the actions between the objects. Places and
transitions are connected by weighted, directed arcs. If no weight is assigned
explicitly, the weight is 1. Places pointing to a transition via an arc are its pre-
conditions. Places pointed to by a transition via arcs are its postconditions. A
transition is called enabled, when all its preconditions are fulfilled, which means
that they contain at least as many markings as the weights of the arcs.
For example, consider a transition that is connected to two preconditions.
Let the connecting arc for the first precondition have a weight of one and the
connecting arc for the second precondition have a weight of three. Then the
transition is enabled whenever there is at least one marking on the first and at
least three markings on the second precondition.
From all enabled transitions one is picked at random and fires, removing the
markings from each of its preconditions and adding a number of markings to
each of its postconditions, again according to arc weights.
In timed Petri nets, transitions have a time delay between being enabled and
firing. They have to stay enabled during the whole delay. The transitions are
also called activities in these nets.
The goal is to evaluate the general usefulness of Petri nets as support tools
for the data analysis and visualisation of cellular signaling data. One objective
is to recreate a detailed simulation of the process and then try to see how robust
the model would be to parameter loss.
3.3.2 Modeling assumptions
The model for the quantitative simulations is chemical reactions, either uni-
directional catalyzed or bidirectional equilibrium reactions. We use chemical
kinetics to describe the rates of those reactions.
Chemical Kinetics
Detailed simulations trace the concentration changes of signaling molecules.
Chemical reactions produce these changes, and chemical kinetics is the the-
ory that mathematically describes the rate of concentration change for these
reactions. The rate of change depends mainly on the rate constants for the
reaction, and on the concentrations of the chemical compounds, temperature,
pressure, and on the presence of catalysts or inhibitors. In biological systems,
pressure and temperature change little and they are consequently hidden in
some constants. For the description of the rate of enzyme catalyzed reactions
the Michaelis-Menten [Hal30] model is commonly used.
The equations for an unidirectional and an equilibrium one-step chemical
reaction are
N∑
i=1
νiXi
kf→
N∑
i=1
ν′iXi
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and
N∑
i=1
νiXi
kf


kb
N∑
i=1
ν′iXi
where vi and v′i are the stoichiometric coefficients of the reactants and prod-
ucts, Xi are the chemical species, kf and kb are the forward and backward
rate constants, and N is the number of species. The unidirectional reaction is
an idealization for reactions which have backward reaction rates that are small
enough to be neglected.
Reaction rate for equilibrium reactions
The extent of the reaction ξ is the stoichiometry-corrected change in the amount
ni of a substance: dξ = dniνi . The conversion rate is defined as ξ˙. The reaction
rate υ is the conversion rate divided by volume V , thus expressing the rate
depending on concentration change. We can also calculate the reaction rate
directly from the concentrations:
υ =
d[Xi]
νidt
= k
N∏
i=1
[Xi]αi
where k is the rate constant for this reaction1 from and αi is the order of
the reaction in respect to the reactant Xi. The overall order of the reaction
is
∑N
i=1 αi. A typical unit for the reaction rate is moles/l · s, where l stands
for liter and s for second, often noted in short as M/s, where M stands for
molar, or moles/l. The unit for the rate constant is M1−ns−1 for an n-th order
reaction.
Integration of this equation to predict the state for the system at a given
timepoint is possible for simple cases, like unidirectional and reversible first
and second order reactions or consecutive or parallel first order reactions. For
complicated networks like the ones we deal with in signal transduction, only
numerical analysis is feasible.
In elementary reactions, which cannot be broken down into several sequential
steps of simpler reactions, the reaction order of a reactant equals its stoichio-
metric factor or αi = νi, and the overall reaction order of all reactants equals
their molecularity.
1This constant can be derived by consideration of microscopical and thermodynamical
properties. For a bimolecular reaction between X and Y it is given by the Arrhenius equation:
k = σ2XY
√
8piKT
µ
P · e−
Ea
RuT
where σ2XY is the collision radius of the two compounds, K is Boltzmann’s constant, T is
the absolute temperature, µ is the reduced mass mXmY /(mX+mY ) with mX and mY being
the respective molecular masses of the two molecules. This first part represents the probability
of a collision. P is a steric factor accounting for the relative orientation of the reactants. The
exponential Boltzmann factor accounts for the fraction of collisions with energy greater than
the necessary activation energy Ea. Ru is the Universal Gas Constant.
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Reaction rate for catalyzed reactions
These are the proposed reaction mechanism and the rate equation for the Henri-
Michaelis-Menten model:
E + S
kf


kb
ES
kp
→ E + P υ = Vmax [S]
Km + [S]
S, E, P, and ES are the substrate, free enzyme, product, and enzyme-
substrate complex. Vmax is the maximum reaction rate, Km is the Michaelis-
Menten constant defined as
Km =
[E][S]
[ES]
=
kb + kp
kf
This model for catalyzed reactions is based on several assumptions, namely
that
1. Only a single enzyme and a single substrate are involved. The enzyme has
only one active site. [E]total = [E] + [ES].
2. The substrate is saturating so that the formation of the ES complex does
not change the substrate concentration, and nearly all enzyme is in com-
plexed form. [S]  [E], [ES] ≈ [E]total.
3. The Briggs-Haldane steady-state approach assumes that a short time after
the start of the reaction, ES will build up as fast as it decomposes and
keep a steady concentration level until near the end of the reaction.2
4. Catalysis is the rate limiting step. Vmax = kp[ES] ≈ kp[E]total
Simplifying Assumptions
For our model, we assume that all reactions are elementary. This simplification
is false in many cases, but allows us to model the network even if the true
reaction orders are not known.
Likewise, we assume that catalyzed reactions follow Michaelis-Menten kinet-
ics. This also is questionable, as many substrates in vivo are not saturating but
show concentrations in the same order of magnitude as the enzyme itself. Also,
several enzymes may share substrates, and several substrates may be valid for
a single enzyme.
In addition to these difficulties, since many signaling molecules have low
copy numbers, local concentrations in the cytoplasm can vary significantly.
A stochastical approach, which does not assume that the molecules are ho-
mogenously distributed in the cell might be preferable. Purely stochastic simu-
lators have been developed [Gil77] for this purpose, but are not employed here.
We employ a special kind of Petri net, called a stochastic activity net to
account for the fluctuations of concentrations and reaction rates in the cell. A
2The original Henri-Michaelis-Menten model uses Ks = kb/kf instead of Km and requires
that enzyme, substrate, and enzyme-substrate complex are in rapid equilibrium, which means
kb  kp. This assumption is called the quasi equilibrium assumption, and is a special case
for the steady state formula.
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probability distribution represents delays in such a net. All delay probabilities
in our model use the exponential distribution, which means that for a given rate
λ, the average time for a reaction to happen equals 1λ , but individual times may
vary.
Many enzymes are regulated or inhibited by competition, covalent modifi-
cation, or allosteric effects. These circumstances were modeled by representing
the explicit mechanism of inhibition or modification.
3.3.3 Modeling procedure and parameters
This section provides an overview about the modeling. A full list of all param-
eters for the nets can be found in Appendix D. Parameter values were taken
from the paper of Bhalla and Lyengar [BI99], as well as from the literature cited
therein.
Run pooling
The stochastic fluctuations in reaction rates lead to rugged changes in the con-
centrations. Each of these rough curves represents one particular instance of
activation of the signaling pathway. To abstract the average behavior of the
pathway, we have to run the simulation several times and average the resulting
curves.
The times for the firing of activities differ from run to run. If we have two
runs, let us consider a time-step in the first run, which does not occur in the
second run. To average the concentrations at this time-step, we interpolate the
concentrations in the second run linearily (See Fig. 3.5).
One run will be longer than the other. We extrapolate the value for the
final timestep in the shorter run by repeating the last timestep. We do not
extrapolate using the incline between the last two measured points in the shorter
run. If we did, we would exaggerate the random fluctuation between of the last
two time steps, because the difference between the length of the shortest and
the longest run can be large, which can lead to impossible negative values for
the extrapolated concentration.
Run 2
Run 1
t0 t1 t2 tn
c
Figure 3.5: Run interpolation. White circles and triangles are interpolated
values, filled ones are values generated by the model. The dashed line is the
averaged curve.
Units
The concentrations of most signal transduction molecules are nM to µM . In
the Petri net representation, integer numbers of tokens represent concentration.
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To avoid fractions, all concentrations are therefore given in nM . Rate constants
for kf and kb are given in nM−1s−1 for bimolecular reactions, rate constants
for kf , kb, and kp are given in s−1 for unimolecular reactions. Km is given in
nM.
3.3.4 Results
To demonstrate the properties of the modeling approach consider the classic
enzyme-substrate mechanism model as discussed above, which does not make
use of some of the simplifying assumptions needed for the Michaelis-Menten
model. It is depicted in its Petri net representation in Fig. 3.6. This model
exhibits unidirecional and equilibrium reactions, as they will be used in the
signaling cascade model later on.
S  E ES P
Kb
Kf
Kp
100 20
 0 0
[ES]
[ES]
[S][E]
Figure 3.6: Enzyme-substrate mechanism Petri net. Circles are places and are
labeled with their name, vertical bars are activities and are labeld with their
rate function. Numbers represent initial place-markings in the net. Kf = 5,
Kb = 4, Kp = 1
The results for a single run and for ten pooled runs can be seen in Fig. 3.7.
The smooting effect of averaging is clearly visible. In the single run simulation,
the substrate was transformed faster than it would be on average. The observed
behavior for the pooled runs matches the theoretical expectations. Initially there
is a fast equilibrium reaction and the enzyme is saturated with substrate. Then
the expected steady state ensues, until the substrate concentration drops enough
to approach the enzyme concentration. Finally all substrate is transformed to
product and the reaction ends.
In the signaling cascade we employ the Michaelis-Menten model to simulate
enzymes. The according Petri net is shown in Fig. 3.8.
The reason for this is that fewer places and activities are needed, and the
Michaelis-Menten model fits to the more detailed mechanistic model closely
enough.
Two interesting points can be observed upon comparing the two models in
Fig. 3.9. First, the enzyme-substrate complex formation with the sharp drop
in free substrate at the beginning is missing in the Michaelis-Menten model.
This is expected, since the Michaelis-Menten equation assumes that the enzyme
concentration is negligible compared to the substrate concentration. Second,
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Figure 3.7: Results for the enzyme-substrate mechanism Petri-net. Upper im-
age: a single stochastic run, lower image: average over ten runs.
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S  P
E
Kp[E][S]/
(Km + [S])
20
100 0

Figure 3.8: Michaelis-Menten enzyme Petri net. Symbols and constants are the
same as in Fig. 3.6. Km = Kb +Kp/Kf
the Michaelis-Menten model completes faster than the detailed model. The
reason for this is that the Michaelis-Menten model assumes steady state during
the whole process, and cannot reflect the slow-down when this assumption does
not hold any more near the end of the simulation. The models fit well up to this
point (at about six seconds in our example). Of course in the Michaelis-Menten
model the enzyme concentration is constant.
After this demonstration of the basic applicability of modeling approach,
we now try to extend it to modeling a more complicated network, namely the
EGF-Ras-MAPK cascade. The cascade model is composed of three subnets (see
Fig. 3.10), which are then combined into one overall net. Two of these serve as
the biological model, while the third regulates the duration of the input signal.
The signal timing subnet works with the aid of an output gate. An output
gate in a stochastic activity net changes the output behavior of a firing activity.
In our case the clock fires on average every second. The output gate then
increases the clock’s number of tokens by one each time, and refreshes the pool
of tokens for EGF. When there are more tokens on the clock than the time limit
allows, it removes all tokens from the clock and from EGF, shutting the signal
down.
Fig. 3.11 shows the results for an example of two pooled runs of this network
with a 10-minute stimulus of 5 nM EGF.
The qualitative behavior of our simulation for the Ras-MAPK cascade (see
Fig. 3.11) resembles the experimental result, with a temporary steep increase in
MAPK-activity. This increase happens faster in the real cell, where the peak
is after about 10 minutes instead after half an hour. Probable reasons for this
difference are the simplifying assumptions about the reactions we used, differ-
ences between measured and physiological rate constants or missing reactions
in our model.
The run also shows two other properties of the model:
First, the temporal behavior of the Shc∗·SoS·Grb2 complex. The concentra-
tion of this complex first increases to a saturation plateau. After a delay in-
troduced by the intermediary reactions, this leads to the formation of MAPK∗.
The negative feedback of MAPK∗ finally removes SoS from the equilibrium for
the complex, and the complex concentration drops.
Second, after 10 minutes the EGF signal is switched off, and the subsequent
internalisation of EGF-bound receptor shuts the signal down.
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Figure 3.9: Results for the enzyme-substrate Michaelis-Menten Petri-net. Upper
image: a single stochastic run, lower image: average over ten runs.
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Name Conc. [nM ]
EGF varied
EGFR 166
PKC 20
GAP 2
GDP·Ras 200
Grb2 1000
MAPK 360
MAPKK 180
MKP1 3
PP2A 224
Raf 200
SHC 500
SoS 100
Table 3.2: Starting pools for the simulation. Species not mentioned have a
concentration of 0 nM . Parameter values were taken from the paper of Bhalla
and Lyengar [BI99].
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Figure 3.11: Results for the Ras-MAPK cascade combined Petri net for a single
run with 10 minutes of 5 nM EGF stimulation.
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Results vary quantitatively from run to run, but the qualitative behaviour
of the network stays the same (data not shown).
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Chapter 4
DISCUSSION
This chapter discusses the results that are presented in chapters 2 and 3 and
points to further areas of investigation.
4.1 Data
What we want to have in the database is the accumulated worldwide knowledge
about signal transduction as it happens in healthy, natural mammals.
Unfortunately, no one today knows what happens in healthy, natural mam-
mals. In finding out about signal transduction, researchers are restricted to
experiments that are conducted in specialized laboratory cell lines, with mu-
tated genes inserted into cells by phages, with in vitro studies using protein
obtained from bacterially expressed plasmids, with knock-out mutations and so
on. This kind of knowledge is published in the seminal literature, together with
reviews. That literature in turn is the deposit that we can mine for data to
input into our database.
How do we extract data from published scientific literature? There are
endeavors to automate this process by parsing the abstracts of biological papers,
checking for names of molecules and keywords that relate them with each other,
like “activates”, “binds” or “downregulates”. Natural language has a lot of
irregularities, and to date, these works have not come up with a satisfying
result, although the idea looks promising.
The most arduous process for obtaining data is undoubtedly extraction from
scientific literature by hand. There are no real alternatives to this method if
validated, high quality data is desired. Apart from an import of 10.073 molecule
entries from the SWISS-PROT database [BA00], public release Nr. 36, which
also is built by manual extraction, all data entries in the database have been
obtained in this way.
We are careful not to mix overviews derived from this data with the data
itself. Rather, overviews should be constructed from the hard, underlying data
automatically and be marked as such. One example is a pathway, which has
been elucidated in its different parts in different organisms. It should be possible
to extract this pathway from the database, and it should always be possible to
find out that it was stitched together.
The task is complicated by the review literature. On one hand it is desirable
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to extract information from this literature, since the information has already
been distilled into an overview by an expert. This allows us to enter consider-
able amounts of pathway quickly, which is important to get adequate coverage
of the field in a realistic timeframe. On the other hand, this information al-
ready contains the kind of abstractions that we want to make possible, but keep
separate from the data, and we enter it as data.
If we were strict, no evidence that has not been investigated experimentally
should be entered into the database. Higher-level understanding constructed
from facts could be shown as such. Since data is entered by hand and the
annotators’ time is limited, this approach is not practical. An annotator would
spend years fleshing out all the details of a small part of the network, which
would be a delight for specialists in this area and make the database next to
useless for everyone else. For this reason, the first milestone for the data is to
provide an overview of the cellular signaling system, a skeletal signaling network.
Once this is in place, the strategy is to flesh out areas of the network according
to demand.
The separation between semantic overview reactions and mechanistic detail
reactions is valuable, as it helps to keep the two kinds of data apart.
In order of decreasing detail and modeling power, and of increasing avail-
ability, the following data can be retrieved from the scientific literature:
• Kinetic data: speed constants, equilibrium constants, and concentrations
of molecules. These last of course would have to represent some steady
state in a given cell and tissue type of a given developmental stage.
• Stoichiometric coefficients: they assign weights to the connections, which
are needed to calculate steady state equations.
• Semantic data: describes the effect of an interaction, but does not quantify,
for example inhibition or activation, or whether an interaction is direct or
indirect.
• Connectivity data: describes which molecule interacts with which other
molecules.
4.2 Database
4.2.1 Graph representations
One can represent the network as a graph with only one type of node, the
signaling compounds, where the reactions are implicitly contained in the edges;
or as a bipartite graph, where the reactions also form nodes; or even as a
tripartite graph, where the connections between reactions and compounds form
nodes. It may be convenient to view the bipartite graph as a hypergraph, where
reactions are the hyperedges, edges with more than two associated nodes.
Many representations are possible. The best representation for understand-
ing the networks is the one that depicts the modeled entities and their reactions
similarly to the way we think about them. Since molecules and their reactions
are the concepts we have for the signaling network, that is the form we chose in
the database. We chose a form where the reactions skipped when the reactions
are not of interest, as is the case for path alignments.
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4.2.2 DBMS
The database could be implemented in any kind of database management sys-
tem, be it a classical relational system, an object-oriented system, an object-
relational system or an even more exotic format, such as a file with Prolog
assertions.
The decision to use an object-oriented system over the better established
relational systems was based on the following considerations:
• As the main point, the expected high connectivity between the data items
(see 2.1 below) makes it improbable that the SQL interface to relational
databases would be well suited for retrieving the data. To construct path-
ways out of single interactions, repeated joined queries for small amounts
of data to the database would be needed. An object-oriented database
with direct pointers between related objects was expected to handle this
requirement much more gracefully than a relational system.
• Object-oriented databases allow direct use of the stored data items in
the application language, avoiding the tiresome object-relational mapping
process. It was expected that the development of the prototype database
would be considerably faster due to this.
• Theoretically object-oriented databases are superior to relational databases.
Some weaknesses of the relational system are that it represents complex
data types only indirectly and cannot return them as results of queries,
it does not directly support inheritance and does not support recursive
querying of structures. Object-oriented systems allow us to represent bi-
ological objects more directly than relations would be able to do. Part
of the project was therefore the evaluation of available object oriented
database technology for biological databases.
Object-oriented databases are better for modeling and prototyping than re-
lational databases. They are worse for integration of their data with relational
data.
The structure presented has been implemented in a prototype database,
under an object-oriented database management system [POE99].
The big advantages of relational DBMS are: they have a solid theoretical
foundation, they are stable and reliable after decades of debugging and engi-
neering, and they are widespread.
In the end the choice of the DBMS is not the deciding factor for a successful
database. It is whether we understand the relationships in the data correctly.
4.2.3 Visualisation
There are several ways to visualize the network data. They differ by showing
more detail or more of the overall network:
1. Single entries are shown as a table of fields and their attributes. In hyper-
text format, all the fields referring to another entry can be made clickable,
so that the user can navigate through the network by hand, brachiating
from entry to entry. This is the most elementary way to visualize the
database contents, and is employed for other kinds of databases, too. The
path or network context is not visible in this view.
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2. Enhanced path layouts have been employed for metabolic networks. To
be able to build these, first some components in the database have to be
defined as core components for linear paths. Then these linear paths can
be laid out graphically in a way similar to textbook schemata [KP94a].
Cofactors and ubiquitous helper molecules like ATP — sometimes called
external components — branch into and out of the main path, and feed-
back and feedforward loops for this path can be shown. The advantage
is that the path looks similar to what biologists or biochemists are ex-
pecting it to look like. The disadvantage is that this expectation may
be based on historic coincidence perpetuated by textbooks. For example
it has been shown [KZL99] that textbook glycolysis, the classic example
for metabolic paths, is only one of multiple possible paths. By assigning
“core” status to selected nodes, a bias is introduced into the database. In
this view, the visualisation context is limited to a linear path. The current
implementation does not support this visualisation.
3. Cascade trees show the whole pathways reachable from a node. They have
to break at loops to do so, and provide a middle ground between the linear
path and the full network visualisation. No status assignment used only
for the visualisation is needed. A disadvantage is that cascades can get
long and hard to grasp when the subnet depicted increases in size. Their
advantage over path layouts is their increased scope of context.
4. Graph layout algorithms are the most general visualisation of a network.
Since optimal graph layout is an NP-hard problem [TBET98], generating
the layout for large datasets has to be done with an heuristic algorithm.
While the network does not look like a familiar cascade or path layout,
graphs are able to show the whole network context. They are a good
visualistation for queries of the type “what influences and is influenced by
this molecule”. Like trees and paths, they can be generated dynamically
from the data.
5. Hand-drawn maps are crafted by human experts and can convey a high
density of information [Tuf90], employing form and colour to show content.
Since in highly connected networks it is difficult to show all interactions
on a two-dimensional map, often a preselection for important compounds
and interactions is made. Usually these maps are made clickable, so that
the shapes representing the various molecules and reactions point to single
entries in the database. Handcrafted maps have the advantage that they
achieve a visual and layout quality that is hard to obtain by automated
means. The disadvantages are that they have to be updated by hand if
the database is updated, that they are static and can only show predefined
pathways, and that they cannot be queried in turn with common computer
programs. Maps are expressive in visualizing the whole network.
The current implementation of the interface is not limited to any one of
those ways to show the data. Depending on his interest, the user can select the
kind of display that best fits his needs, or switch between a high-level view for
context and a detailed view to zoom into more information. No one single way
to show the data is the best. A good combination of all ways is.
4.2. DATABASE 69
4.2.4 Class layout
Object-oriented methodology [Boo94] suggests an iterative development process.
After specifying, a prototype implementation is created. The specification is
modified and the prototype updated based on observations with this prototype,
and with better understanding of the problem domain that comes with creating
and using it.
This work lays out the conceptual design of a signal transduction database,
and is the result of several such iterations. Implementing the design was ex-
tremely helpful in testing ideas and locating problem areas that I did not antic-
ipate originally. Many of the insights about the database schema were gained
by filling the database with increasingly detailed data, which then suggested
improvements.
In this section I discuss reasons for some of the design choices and point out
differences between the conceptual database and the current prototype imple-
mentation.
Molecule classification
A Molecule entry stands for every kind of agent that can signal. It may be
beneficial to subclass Molecule with Basic, Family, Motif and State to enable
type checking of the programming language for the different kinds of Molecule
entries in the database. This is not currently implemented. A field named type
in Molecule serves as a temporary fix. This classification contains different kinds
of Molecule entries, not different kinds of molecules. A motif is not a molecule,
and neither is a protein family. That is what sets it apart from the next kind
of subclassification:
It is possible to subclass Molecule with classes like SmallMolecule, Protein-
Molecule or EnzymeProteinMolecule. Some molecules share properties that set
them apart from other kinds of molecules and that can be used to group them in
such a class. For example, all Proteins have a sequence and all enzymes catalyze
reactions.
There are efforts to build Ontologies1 for biology in general and for bio-
molecules and genes in particular. Ontologies for biomolecule families resemble
class hierarchies and usually subclass Molecule with classes like the ones dis-
cussed above.
One question is where to stop with this subclassification scheme. For en-
zymes there exists a hierarchical classification scheme, the EC nomenclature
[otIUoBB92] which encompasses over 3.500 members.2 A single entry of this,
EC 2.7.1.112, represents all protein tyrosine kinases. Then the different protein-
tyrosine kinases are in turn grouped into 23 families, which finally hold the
proteins [Han94]. Sometimes, as in the case of the Ras superfamily, there are
in turn subfamilies, which finally hold the proteins. A consequent use of sub-
1An Ontology is “the specification of a conceptualisation that is designed for reuse across
multiple applications and implementations” [Kar00]. In other words it is a formal way to
write down or store the concepts about the world or, usually, a certain aspect of the world,
and their relations to each other.
2The EC nomenclature is based on the reactions that the enzymes catalyze, so it is actually
a reaction classification. It is hierarchical. At the top are six broad classes of enzymatic
activity; at the bottom are around 3,500 specific reaction types. EC classes are named with
four numbers separated by periods.
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classing must represent all those classes of molecules as classes of objects. The
instances then would represent the actual molecules.
Clearly, for practical reasons it is not sensible to mirror the whole classifi-
cation hierarchy in the class hierarchy. The classification of proteins tends to
change over time, as new proteins are discovered and better understanding of
the family relations is gained.
Since the best level of subclassification is not evident, the decision is made
to start without any source-level subclassification of the Molecule class and
introduce source-level subclasses only when practical experience indicates that
it would be advantageous to do so.
Instead, a “soft” system of subclassification is used, which allows the database
curator to introduce family relationships whenever they are needed, to arbitrary
nesting levels. It is not constrained to a hierarchical relationship of single in-
heritance. Some proteins may be grouped as members of different strata. For
example, a receptor Tyrosine kinase might be classified as a receptor as well as
a Tyrosine kinase.
We rely on the domain knowledge of the annotators to uphold a correct
classification structure. This assures correct biological relationships and relieves
the burden on the input client developers. A good input client is as important
as the relations in the database are, because no data can be entered effectively
without it, and without data even the best database layout is worthless. Usually
the supporting software takes more time to implement than the database layout.
Adding an Orthologues collection
It is an option to separate orthologues and paralogues and add a separate or-
thologues collection, in addition to the groups collection used for both at the
moment. This information is already indirectly in the database, though, since
orthologues have different species locations from each other. The common col-
lection makes it clear that in both cases we have similar sequence or function,
and we keep them together.
Adding a Connection class
Connection is not currently implemented in the database, but is in the process of
being so. Connection does not inherit from Component, since it does not share
Component’s attributes. It is necessary to introduce this class, for the reasons
given in 2.4.8. Connection is already part of the relational port of Transpath.
Reaction classification
By subclassing the generic Reaction class into Semantic and Mechanistic, we
can employ type checking to differentiate the two kinds of reaction. Introducing
a Translocation subclass for Mechanistic with a second location property allows
us to represent translocations: the first location is where the molecule comes
from, the second one, where it goes to. Since we again can use type checking
to find translocations, this is faster and preferable to linking the Connections of
the reaction with Locations, which is the alternative (compare 2.4.8).
To model a translocation in the current implementation, which does not
have a Connection or a Translocation class, we have different state-entries for
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the same molecule in the two locations, so that it can be seen by the reaction
as two molecules, for example NF-κB(cyt) and NF-κB(nuc). This practice is a
temporary fix, since it mixes the Molecule with the Location class and smears
the definition of those two concepts.
Even further subclassing of the Mechanistic class in classes like Catalyzed
and Complexation is possible. We could introduce one type of reaction per
mechanism. The reasons for refraining from implementing this subclassification
so far is that the data in the literature extracted does not mandate it: no
detailed information about inhibition mechanisms is available.
Semantic and mechanistic reactions
Both kinds of reactions have their place in the database, semantic for overview
information, mechanistic for detailed, primary information. The higher detail
level makes the mechanistic view more usable for quantitative simulation.
The main weakness of the semantic view is the implicit assumption of only
two states. Molecules with more than two relevant states cannot be represented
correctly.
Detail level in modeling the reaction mechanism
When we use elementary primitives to represent complex concepts we obtain
internal models where many primitives are needed to reflect one of the concepts.
Complexity in concepts is reflected into complexity of structure. This reflection
does not look similar to the concept and is difficult to construct by hand.
Complicated models of many primitives are only useful when they can be
automatically generated from intelligible, conceptual models. The results ob-
tained with such models have to be translated back into the language of the
original concepts to be useful. An illustration: in programming, a few expres-
sive high level language instructions are translated into many simple machine
code instructions, which are totally unintelligible to most humans. This works
because we have compilers, programs that translate our conceptual model that
is intuitively understandable for humans into another one which is understood
by the computer.
Applied to our particular problem this means that expressive reactions need
fewer edges and nodes, since the edges are colored. Reactions can be modeled
on different levels of abstraction:
On a low level is a purely mechanistic view, which consists of elementary
reactions only (see 3.3.2). Nothing has to be known about any of the molecules
or reactions involved, and reactions are, with rare exceptions, limited to aggre-
gation of two molecules, transformation of a complex into another, and disso-
ciation of a complex into two molecules. This leads to “dumb” reactions and
many intermediary species, or nodes.
On a high level, we model a complicated regulatory process as a single Re-
action entry, which allows us to quantify relations between enzyme, cofactors,
activators and inhibitors in the reaction description. These species may com-
pete and the state of the enzyme in the reaction may depend nonlinearily on the
relative concentrations of activators and inhibitors. One approach to capturing
this kind of competition can be seen in the elaborate schemes of enzyme kinetic
formulas[Seg75]. The whole network of elemental reactions between all these
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molecules is integrated into one equation. This leads to “smart” reactions, and
only one node per reaction.
The mechanistic reactions we use represent a middle ground between the
two extremes. We break up complicated regulatory mechanisms into smaller
steps, but integrate the enzymatic catalysis into a single Reaction. If we chose
to forget about the meaning of the enzyme we would need more nodes to model
the mechanism of the process — compare 3.8 and 3.6.
For a signaling reaction in the cytosol, we usually have two or three signaling
inputs to the reaction, either two molecules that interact directly, or one or two
molecules aided by an enzyme.
The decision as to which molecules will react in a real-life situation will
depend on the concentrations of the molecules, on their condition, and on the
binding constants. Thus competition or inhibition decisions based on the mech-
anistic model can only be seen during actual simulation of the mechanism. To
support this we need contextual information for the molecules and reactions,
like stoichiometric indices and speed constants.
Since an enzyme might work on different substrates with different speeds,
we cannot store these parameters in the Molecule entry and use the Reaction
for this purpose.
4.2.5 Interface
There are two common ways to make biological databases available:
1. World wide web pages, often generated dynamically by server side scripts
2. FTP-download of the interface software and data flatfiles, for local instal-
lation
When considering which kind of interface to develop for querying and filling
the database target properties are: portability, ease of use, support for multiple
concurrent users, and accessibility.
Web interface
The web-based approach has several advantages: first the user does not need to
download and install the software. Since there is no local installation, portability
is not an issue, the database will be available to anyone with a web browser.
Second, web pages have a broad user community and the metaphors they use,
links and forms, are well understood and therefore easy to use. Third, multiple
users are supported automatically through the web server. Fourth and last, the
user always and from anywhere in the world has access to the latest version of
the software and the latest release of the database without having to update
explicitly. Hence a WWW interface is chosen as the primary interface for the
database.
Java (see Appendix A) is a portable, object-oriented language that can be
used flexibly for web applications, as applets on the client side, as servlets
on the server side or for stand-alone applications. It is supported by several
object-oriented database management systems. These two properties make it
the language to fit both the object-oriented modeling of the database and the
web-based publication of its contents. Therefore Java was chosen as the imple-
mentation language.
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General architecture
There are several designs to implement the web interface:
1. Straight pregenerated HTML pages that hyperlink to each other.
2. Applets that retrieve data from the database over the net.
3. Template HTML files that are dynamically filled with data from the
database, like Java Server Pages.3
4. Servlets that dynamically generate HTML pages filled with data from the
database.
Static HTML pages are technically the simplest solution. They have to be
re-generated every time the database content changes. Their disadvantage is
the missing computational capability, which makes it impossible, for example,
to answer pathway queries. Applets have the disadvantage that they have to
send requests for data over the network, which can be slow if data is retrieved
in small quantities. Template imbedded Java code is a good solution if there
are considerable amounts of boilerplate HTML, and little snippets of code. If
the pages mainly consist of dynamically generated content, it is more sensible
to embed the HTML into the Java code using normal servlets.
A web-based input client makes it easily possible to update the database via
the network. There is no limit to where in the world the annotator sits, and
multiple annotators can be supported.
4.3 Previous work
This section gives an overview on what databases, models and simulation engines
for bionetworks exist.
4.3.1 Databases
Databases are static models of networks. The static model contains the sig-
naling compounds and their interactions. The interactions include additional
information like parametric constants.
Several other efforts to manage signal transduction data exist:
CSNDB (http://geo.nihs.go.jp/csndb.html) The cell signaling networks
database [TIK00] strives to be a general database on signal transduction,
and is the only other database with comparable aims. CSNDB is devel-
oped and curated by Takako Takai-Igarashi, National Institute of Health
Sciences, Japan. CSNDB provides a rule-based linear pathway visualisa-
tion in addition to plain entries. In contrast to Transpath, CSNDB focuses
on semantic reactions. Information is extracted mainly from the review
literature. With friendly consent of Dr. Takai-Igarashi, the data set of
CSNDB is available under the Transpath interface (compare 2.5.6).
3Java Server Pages, JSPs, are special kinds of servlets that allow to embed Java source
code into HTML pages, to be compiled and evaluated on the server side when the pages are
requested.
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KEGG (http://www.genome.ad.jp/kegg/kegg.html) The Kyoto Encyclope-
dia of Genes and Genomes [KG00] is developed at the Institute for Chem-
ical Research, Kyoto University under Minoru Kanehisa. KEGG focuses
on genes and metabolic pathways and is based on binary relations. It has
an additional database module, PATHWAY, to store information about
signal transduction intercations, in the semantic view. KEGG provides
hand-drawn maps as an additional visualisation.
stke (http://www.stke.org/) The signal transduction knowldedge environ-
ment is developed by Stanford University Libraries in collaboration with
Science. It is a non-formalized collection of information on signal transduc-
tion in form of an online publication, consisting mostly of review articles
and clickable maps.
SPAD (http://www.grt.kyushu-u.ac.jp/spad) The The Signaling Pathway
Database is maintained by Hakozaki Higashi-ku, Japan Graduate School
of Genetic Resources Technology, Kyushu University. It provides hand-
drawn clickable maps as the only interface, categorized by extracellular
signaling molecule.
None of these databases stores the states of the signaling molecules. For
many cases, molecular states are necessary to describe adequately the signaling
process. Consequently, all of these databases strive to be information sources
only, and do not support simulation needs. Most of the databases only support
direct edges between molecules, corresponding to a common graph, and do not
model the reactions as separate nodes (CSNDB is the notable exception).
Very Large System Integration (VLSI) Design
VLSI design [Ger99] is used for the modeling of electronic signaling networks
or circuits. The similarity between biological signaling networks and microchip
signaling layouts is suggestive [HHLM99] and the assumptions about modular-
ization (see 4.6) suggest application of the same techniques that are used in
electronic VLSI design for modeling the very large biological systems. VLSI
modeling is conducted on multiple layers of abstraction, and one of the difficul-
ties is to find analogues for biological systems. In that context the gate-level
logic models seem to be most amenable.
McAdams [MS95] used this approach by modeling gene-regulatory networks,
mixing in nonlinear differential equations for selected critical control elements,
and Arkin [AR94] and coworkers are developing an environment dubbed Bio/SPICE
based on these assumptions. Any such application will ultimately need a struc-
tured “parts catalogue” or library as is provided by the database developed in
this thesis.
4.3.2 Simulations
Simulations are dynamic models of networks. The starting conditions are the
input to the model.
Network models of all kinds have been used on research topics as diverse
as electrical circuitry, traffic control and gene-regulatory or metabolic networks.
Since we are interested in ways to model networks, we present an overview based
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on the kind of model used, not on the kind of application domain, but will
cite examples from biological modeling. The classification of methods follows
[HT98].
Logical models
These are the simplest possible models. Components in the model are in one of
two states, “on” or “off”.
Boolean Networks A Boolean network calculates the state of a node in the
network from the state of incoming connected nodes. They are able to
express positive and negative feedback loops. Parameters are a set of rules
and a set of Boolean tokens that defines which cells are on in each iteration
of the network. It is computationally cheap and has been used before to
model gene-regulatory networks [TR99]. Since the model is Boolean only,
no quantities can be expressed. Thus amplification, delays and thresholds
cannot be modeled intuitively.
Discrete models
These models do not use exact concentrations or rate constants. They represent
a middle ground between the more exhaustive differential equation systems and
the simplified logical models.
Petrinets Petrinets have a mature theoretical background [Rei91], and nu-
merous tools for analysis and running simulations exist. There are a lot
of variants, including colored and timed Petrinets, but unfortunately, as
these variants get more expressive, they are more difficult to treat with
the basic theory. Interesting system properties that can be analyzed with
Petrinets are liveness and reachability. Hofesta¨dt and Thelen [HT98] used
Petrinets to simulate metabolic networks.
Stochastic Activity Nets (SANs) SANs are a variant of Petrinets, which
allow additional conditions upon which transactions fire, thereby making
it easier to model behavior without introducing many additional places.
Switching time here is based on probability distributions, overcoming some
limitations most other discrete models have. These models were investi-
gated further and are discussed in more detail in 3.3.
There are still only discrete sets of tokens moved in the network. One
can assimilate floating-point behavior by large numbers of tokens, so that
one token in effect equals the smallest possible fraction of a unit to be
represented. Mounts and Liebman [ML97] used a SAN model for blood
coagulation.
Rule-based systems Implementations include Prolog, Lisp, or expert system
shells. The network is modeled as a collection of IF x THEN y rules. A rule
fires, when the expression in its preconditions x holds, setting the values
in its post-conditions y. There are efficient algorithms, like RETE,[For82]
to re-evaluate if a rule fires when some arbitrary condition of the network
is changed. The range for parameters can go from Boolean markings up
to floating point numbers, depending how the rules are formulated. Rules
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represent interactions. There are commercial tools to do the computation.
The big advantage is that this model closely mimics the way biologists talk
about signal transduction, and that the rules for the interactions can be
arbitrarily complex, but will also work with crude information. Brutlag
[BGM91] used rules to model enzyme behavior (for DNA polymerase).
Neural Networks/Parallel Distributed Process-networks A layered net-
work of neural units with input layer, hidden inner layers, output layer plus
training program for weights is the neural network approach. This method
goes in the direction of machine learning. Only connectivity and exper-
imental data are needed. The disadvantages are that extensive datasets
are needed for training, and, while the model may be able to predict the
outcome, it explains nothing. Bray [Bra90] had an example application.
Continuous models
These are the most detailed models and they are commonly used for quantitative
simulation. They need kinetic parameters and have to date been used most
often. Because of their hunger for information usually only small, well known
systems can be modeled.
Quantitative modeling gives the highest predictive precision and allows the
quantification of signal transfer.
A mature theory and several databases exist for metabolic networks and
their analysis, which have been largely modeled with differential equations
[SDF99, KP94b]. In metabolic networks the model is that of small molecules
being transformed by enzymatically catalyzed reactions. Thus there is always
a flow of mass through the network. Nothing is said about the regulation of
the enzymes - if they are present, they are assumed to work. In regulatory
networks, information is flowing, and often does so without mass being passed
on. Consider the catalysis in regulatory cascades: here you have futile cycles
between the active and inactive state of the enzymes from a mass-conservation
point of view, but what really counts is the passing of information that man-
ifests in this state-change. These processes will not yield usable results with
present day tools for metabolic network analysis.
Differential equations The network is modeled as a collection of differen-
tial equations, where reaction rates and compound concentrations are the
variables. These are then solved numerically for each time step. Stoi-
chiometric coefficients, starting concentrations and rate constants for all
interactions are needed [MS95, S+99].
Stochastic Processes An alternative to differential equations, which uses fewer
assumptions about the distribution of molecules in the cell and is advan-
tageous for low molecule copy numbers, is the use of stochastic processes
[Gil77]. In this case the absolute molecule numbers have to be estimated,
and the system behaviour is predicted by sampling multiple runs and av-
eraging over them.
Colored Petri Nets Some colored Petri nets allow arbitrary attributes on
their markings. Ku¨ffner et al. [KZL99] constructed a Petrinet which used
this feature to change the marking attributes (representing concentrations
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Figure 4.1: Information flow in signaling cascades. Solid ellipses are inactive
enzymes, striped ones active enzymes. Solid arrows indicate flux of mass while
dashed arrows indicate flow of information.
of compounds) instead of the number of markings. All the comments made
for differential equations apply here.
4.4 Applications
Everything that has been said in 4.2.4 for static models applies for dynamic
models, too: The best representation for understanding the networks will again
be one that depicts the modeled entities and their reactions similarly to the way
we think about them.
All simulations and analyses with the database can yield no other result than
what the database provided. With the data still being fragmentary, results of
such analyses may vary significantly from the real outcomes in the laboratory.
As more and more data is added to the database and knowledge grows, the
model will come closer to the real biological system, and so will the predictions.
The methods that have been employed in this work and the tools developed to
do so, can be applied to any later, more comprehensive dataset.
Often only the general nature of molecular interaction is known. Stoichio-
metric factors, rate constants and reaction rates are missing in many cases. Since
timing can have drastic effects on signal network behavior [Ger99] it may not
be possible to conduct detailed simulations before such data becomes available.
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4.4.1 Path alignment
Our main assumption was that only the shortest paths are relevant. There are
some situations where a longer path makes sense, for example in a cascade which
serves to amplify the signal. We ignored these, to get something we could work
with.
Hypotheses
Figure 4.2: Pathway hypotheses. Left, generic pathways link to a variety of
receptors and transcription factors. Right, different classes of receptors and
factors have their own specific pathways, which can crosstalk.
One hypothetical model for signal transduction is that a set of receptors
leads to a few general pathways, which funnel the signal to a set of transcription
factors. Specificity is mainly achieved by differential expression of receptors and
factors between different cell types.
An alternative hypothetical model is that different kinds of receptors connect
to different, specific signaling pathways, and these pathways may interact via
crosslinking molecules.
Fig. 4.2 shows the hypotheses graphically.
Interpretation of the results
If the first hypothesis is true, the paths should be similar to each other in the
middle, since the middle is the part of the sequence that reflects the transduction
channel.
If, on the other hand, the alternate hypothesis is true, then the the paths
should be similar to each other at their ends. The discussion refers to the
similarity tree in Fig. 3.2.
Similar paths will cluster together. If we find that in one branch of the
tree all the paths clustered together vary in both their signaling molecule and
their transcription factor, then the clustering is due to a shared inner stretch of
sequence, and the funneling model is true for this group. For example, the Ras-
MAP kinase cascade connects EGF, PDGF, ACTH and CRH to AP-1, which
means to Jun and Fos, Elk-1 and CREB2.
4.4. APPLICATIONS 79
If we find that all paths in one branch of the tree start from the same
signaling molecule or family of signaling molecules, then the clustering is due to
a signaling pathway that is specific for that family. This pathway is connected
to other pathways by means of a crosstalk point. This is for example the case
for the Interleukines, which signal over STAT proteins. The same reasoning
applies to clusters ending in a common transcription factor or family of factors.
One caveat is that the quality of the alignments depends strongly on the
detail and quality of the pathway descriptions in the database. One must use
the same level of detail throughout the database. If we use many reactions
to describe one step in detail, this step will contribute to the alignment more
than it should. If we use one reaction to subsume a whole signaling cascade
then the cascade will not contribute as much as it should to the alignment.
For the example pathways mentioned, two such cases in the CSNDB data can
be found. The “CRH → ACTH” reaction describes extracellular hormonal
signaling instead of signal transduction signaling and the “MAPK cascade”
molecule entry represents all the reaction steps and molecules of the MAP kinase
cascade.
The algorithm and method produces alignments that grow more useful as
the number and quality of pathways in the database grows.
If there are mixtures of both modes, where a specific pathway is hooked up
with a common pathway, the length of the string for each sub-alignment decides
the outcome of the clustering. One example is the IL-9 STAT signaling pathway,
which leads into the MAP kinase cascade.
Conclusion
The tree shows that the data suggest neither of the two extreme hypotheses is
correct, and that a mixed model would be more appropriate.
4.4.2 Boolean networks
The inference process behind Booelan networks closely mimics the way biologists
are often forced to think about signaling processes: one active species goes up in
concentration, suppressing another one, which goes down or activates another
one, which also goes up. Even with this over-simplifying approach, networks
rapidly grow unpredictable when evaluated manually.
The Boolean approach formalizes this process and makes it possible to pre-
dict such outcomes for large networks. It finds emergent behavior which is not
obvious from inspection of the network, like the oscillatory cycle in our example
in Fig. 3.4.
It has been discussed that it is possible to capture oscillatory behavior with
Boolean networks for regulatory networks that eludes continuous models of the
same system [HL99]. We show that it is easy to evoke such behavior within
Boolean networks applied to signal transduction cascades.
The model as it stands predicts the persistent activation of the feedback cy-
cle. Even after withdrawal of the stimulus later on, the fully activated cycle stays
active, as shown in basin number three. Quantitative simulations [BI99] sug-
gest that this is only the case for strong and sustained activation. The Boolean
network is able to capture the qualitative behaviour, but not the quantitative
aspects.
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Such quantitative models are the subject of the next section. For now we note
that Boolean networks provide a conceptual, rough estimate how a signaling
system might behave.
4.4.3 Petri nets
We used Petri nets to conduct a quantitative simulation, which depends on
numeric paramters for the reactions. If as a crude simplification kf , kb and
kp are set to one, the dynamic behavior totally breaks down. This is to be
expected: equilibrium or catalyzed forward and backward reactions progress
with the same speed, and consquently token numbers oscillate around their
starting values, varying only according to the probability distribution. It shows
that rates are critical for the behavior of the system.
Stiffness
Straightforward Petri net simulations of chemical kinetic systems are stiff [AS92].
The fastest process in the whole system will dictate the stepwidth of the sim-
ulation, even if the interesting changes are taking place at a much slower rate
and need a bigger stepwidth.
For example, a simple equilibrium reaction after a short while will reach a
state where the markings oscillate minimally around the equilibrium value. If we
treat the forward and the backward reaction independently and their rates are
a thousand times as big as the rate of the reaction of interest, we will produce
two thousand superfluous steps for each step we are interested in. The amount
of useless data we generate is uneconomical and may even be prohibitive.
The stiffness makes automated generation of Petri net models from the
database problematic, and proves limiting for the size of the simulated net-
work. In the original model several other subnets were included, for example
a subnet for the activation of PKC, which contained fast equilibrium reactions
only and made the size of the simulation output too big to handle.
In the case of PKC, running the PKC subnet alone showed that after a
second an equilibrium of 20 nM is reached. Since this process is much faster
than the cascade process itself, the concentration of PKC could then be given as
constant 20 nM for the cascade model. In other cases, such simplifications may
not be possible, especially when feedback processes influence the equilibrium
level later in the simulation.
Therefore, to make qualitative analyses with Petri nets feasible, analytical
methods to simplify the model would have to be employed. One possibility of
course is to have a human examine the networks and conduct such analyses.
For automated prediction of network behavior, however, they also would have
to be automated.
For the modeling approach pursued here, Petri nets provide no advantage
over systems of differential equations as far as parameter sensitivity is concerned.
The telescopic property of Petri nets, which means that nets may be com-
posed from subnets, is valuable for successful model building by humans as it
helps to keep the complexity at a manageable level.
Even more important is the graphical map that the Petri net directly fur-
nishes for the network of interactions. It helps to localize interaction parameters
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and understand the relation of elements to each other. For a differential equa-
tion model that was built for comparison purposes, the Petri net maps proved
indispensable.
4.5 Status and future of the database
The database is available to the academic community on the WWW under
http://transpath.gbf.de/.
Biobase GmbH, a company specializing in databases for gene-regulation,
has aquired the rights for Transpath. The implemented prototype is used by
Biobase GmbH for storage and annotation of signaling pathways. Currently
five annotators are entering data into the system. 2373 Molecule are linked by
2684 Reaction entries, for which 405 References have been evaluated. Biobase
is further developing the database.
Many companies have a huge investment in know-how and licences in re-
lational databases. They need a good reason before they accept the cost to
retrain their staff and convert their legacy data — or worse, administer and
curate both systems concurrently. Relational databases work reliably. Object-
oriented DBMS are younger, and less mature and reliable, which is a drawback
if a company depends on the database’s availability. These are some of the
reasons why OODBMS have a market share below 10 percent, in spite of being
theoretically superior.
It is easy to port tables from several relational databases into one and link
them to integrate different databases. Biobase offers other databases, which
reside in a relational DBMS. To normalize data between these databases, they
share certain tables, for example the Reference table for literature citations.
To integrate Transpath with their other databases, Biobase GmbH is creating
a relational version of Transpath. This version will be sharing the References
of the common Reference table, and provide a framework for gene-regulatory
networks between the transcription factors of the TRANSFAC database.
CytomerTM[W+00] is a relational database that specializes in representing
hierarchically organized expression spaces like organisms, systems, organs, tis-
sues, developmental stages and cell types, unified in a hub table. In the rela-
tional version of Transpath, this table will replace the corresponding fields from
location.
4.6 Open questions
It is an old adage that biologists know more about biology then they are able to
express. There are several interesting assumptions and questions about signal
transduction networks which have not been investigated systematically, as such
an analysis is not possible without an extensive data collection:
What is a signal transduction pathway?
Even though this whole work is preoccupied with signal transduction or signaling
pathways for short, there is no common definition what a signal transduction
pathway is.
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Figure 4.3: Ras pathway crosstalking. Image taken from an article in Cell[ME98]
discussing the nature of pathways.
In biological papers, pathways are named after key molecules (“MAPK cas-
cade”). In that context, pathway refers to a more or less linear path from
receptor to transcription factor, even though usually some of the molecules in-
volved are also found in other pathways. The influence that one pathway exerts
on another one via these molecules is called crosstalk. The question is how to
define a boundary for a pathway under these circumstances. The classification
of molecules into pathways has historical reasons and is not explicitly based on
qualitative differences of the interactions. One reason for this is that it is easier
to think about the network as pathways connected by crosstalks.
It is not known to which extent crosstalking influences the signaling behav-
ior. Are crosstalks mere by-products of a system that is mainly linear in its
transduction activities from plasma membrane to nucleus, or are they integral
to the system?
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While detailed data may be available for single elements in the network, no
such data exists that measures the quantitative properties of pathways, like their
length, size, number of feedback cycles, number of crosstalks between pathways
and area reachable from any point in the network. Probably this is so because
we have no generally accepted definition as to what constitutes a pathway in
the first place.
Is the network built from modules?
Man-made complex systems such as airplanes, microprocessors or software ap-
plications share one common trait: they are built up from modules.
The more interconnections exist between the different parts of a system, the
harder it gets to predict how the system will react. It also gets harder to change
any part of the system without upsetting another part. When systems reach a
certain size, they will become unmanageable and non-understandable without
decomposition into modules.
If we compose the overall system of simpler subsystems or modules, we can
divide and conquer4. Each module must be simple, so that we can understand
and predict the inner behavior. Then we forget about the inner workings of
the module and regard its overall function. We have created a building block,
decoupled from the internal interaction network. We now can construct a system
by plugging together modules and, again, we can understand the workings of
this higher-level system and are able to predict its behavior. In turn we can use
it as a module for building an even higher-level system.
Because this method of recursive modularization is the only one known to
us which makes construction of large complex systems possible, it is tempting
to suppose that biological systems work the same way. And on higher spatial
levels of the organism it is evident that this is the case (see 1.2.1). But it is
not clear how far this holds for intracellular signaling networks, even though we
would expect to see modularization for a system with hundreds of components.
It would certainly facilitate understanding of the signaling network if we
could come up with a model for modules. The question is what criteria should
be used to define the boundaries between these modules? Finding a correct
segmentation of the signaling network is the most pressing challenge that lies
ahead in this area.
4.7 Summary
Transpath is an information system on signal-transduction networks. It focuses
on pathways involved in the regulation of transcription factors. Molecules and
reactions are the nodes in a signaling graph. They are stored in an object-
oriented database, together with information about their location, quality, fam-
ily relationships and signaling motifs. Also stored are links to other databases
and references to the original literature. Transpath differentiates between the
4There are two approaches in building large systems, the top-down and the bottom-up
approach. In the top-down approach we start from the overall system and seek to segment it
into simpler subsystems. In the bottom-up approach we start from simplest subsystems and
build them up to the overall system. In practice, usually a mix of both methods is employed,
since both are expressions of the same idea: namely, that the system is composed from simpler
subsystems.
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states of a signal molecule, and can adequately describe the reaction mechanisms
of signaling interactions.
It is available over the web through a Servlet-based interface, that creates
dynamic content directly from the contents of the database. Pathway query
mechanisms and several kinds of display are provided for the database in addi-
tion to text-based queries and information on single entries.
We show that the database is useful for analysis of the signaling network
and can provide the basis for simulations.
“A problem worthy of attack
proves its worth by fighting back.”
— Paul Erdo˝s (1913–1996)
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Appendix A
MATERIALS AND
METHODS
Operating System Microsoft Windows NT 4.0
Development was conducted on a PentiumIII/Microsoft Windows NT 4.0
workstation, on a Sun UltraEnterprise 450/Solaris 2.51, and on a Pentiu-
mII/RedHat Linux 6 cluster with 8 nodes.
Database POET Object Oriented Database Management system
POET Java developer license and object server version 5.0 and 5.1 for
Windows NT from POET Software Corporation, 999 Baker Way — Suite
200, San Mateo, CA 94404 were used as the OODBMS.
There is a multitude of both academic and commercial OODBMS avail-
able. Since support and availablity of the database management system
was critical for this work, the decision was made to use a commercial
product. The database should be ODMG-compliant [Ce97] as much as
possible and should be as mature a product as possible.
Because of the fast development, printed surveys on available database
systems tend to become rapidly outdated. Several internet publications
were reviewed instead [Sch98, Cha98, Bar98], leading to a preselection of
Object Store, POET Object server and Objectivity. Out of these Object
Store and POET were selected for evaluation, because both offered free
evaluation licenses. Object Store was the market leader and POET is a
partly Germany-based company, which would make support and contact
easier.
Object Store did not support OQL queries. Since it was foreseeable that
querying the data would be required, this would have meant implementing
the query functionality in the application. I was not interested in invent-
ing the wheel all over again, and the choice was made to use the POET
database, which supports a subset of ODMG OQL.
Application Language Java
To make the code as portable as possible and ease creating a web-based
interface Java Development Kit 1.16 through Java 2, Version 1.22 by Sun
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Microsystems, Inc., 901 San Antonio Road, Palo Alto, CA 94303 USA were
used. Java is a modern object-oriented programming language that runs
on a virtual machine instead of the actual hardware, making it platform
independent as long as a virtual machine for the target platform exists. It
fulfills all requirements mentioned in 1.3. Java can run as applets in a web
browser, or as servlets in a web server, as long as they provide a virtual
machine.
The development kit can be downloaded from
http://java.sun.com/j2se/.
Scripting Perl - Practical Extraction and Report Language
For various data transformation and scripting tasks the the latest versions
of ActiveState port of Perl[WCS97, SC97] were used. Perl has strong
inbuilt pattern matching capabilities, which considerably ease processing
of text files. Compared with shell scripts, it also has the advantage to
work over different operating systems .
Perl is Open source distributed under the Perl artistic License. It can be
downloaded from http://www.perl.com/pub/language/info/software.
html or http://www.activestate.com/Products/ActivePerl/. Vari-
ous additional packages for Perl and information can be obtained from
the Comprehensive Perl Archive Network (CPAN) at
http://www.perl.com/CPAN-local/README.html or one of its mirrors.
Web Interface HTML 4.01, XHTML Transitional, PaintShop Pro 4.01 and
CorelDraw! 7.0, JavaScript and dynamically created pages
Static web pages were hand-written in HTML 4.01 [Rag00] and partly
translated into XHTML 1.0 [P+00] with the HTML Tidy [Rag00] utility.
Dynamic effects for these static pages were created with JavaScript [Hei97,
Jav00].
GIF images for pathway representation and web layout were created with
CorelDraw! 7.0, available from Corel Corp., 1600 Carling Ave., Ottawa,
Ontario K1Z 8R7, Canada http://www.corel.com/ and with JASC Paint
Shop Pro 4.01 http://www.paintshoppro.com/.
The dynamically created pages were produced by Java servlets that read
data out of the database, processed it and formatted it as HTML for
presentation.
Editors Symantec Visual Cafe´, JPad, UltraEdit32, TextPad, Emacs
Java source code editing and testing was done with Integrated Develop-
ment Environments (IDEs), first with Visal Cafe´ by Symantec Corpora-
tion (now distributed by WebGain http://www.visualcafe.com/), later
with JPad available from Modelworks Software, 14612 NE 169th Street,
Woodinville, WA 98072-6938, USA http://www.jpadpro.com/.
The composition of the document you are reading, some Java editing,
HTML souce writing, Perl scripts and general all-purpose text file editing
was done with UltraEdit32 by IDM Computer Solutions, Inc., 8209 Chest-
nut Hill Ct., West Chester, OH 45069, USA http://www.ultraedit.com/,
with TextPad by Helios Software Solutions, PO Box 619, Longridge, PR3
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2GW, England http://www.textpad.com/, and with GNU Emacs for
Windows version 20.4 available under the GNU public license from GNU
Software http://www.gnu.org/software/emacs/windows/ntemacs.html.
Webserver Apache/Jserv
The webservers used for the public presentation of the database are the
Apache HTTP server Windows port by the the Apache Software Founda-
tion available from http://ftp.cs.tu-berlin.de/pub/net/www/apache/
and the Apache JServ servlet server available from
http://java.apache.org/, both distributed under their respective pub-
lic licenses.
Versioning CVS
Source code versioning was done with the CVS open-source network-
transparent version control system available from
http://www.cvshome.org/CVS/index html.
DDLab DDLab [Wue99] is an interactive graphics program for researching dis-
crete dynamical networks. A network can be set up with any architecture
from cellular automata to “random Boolean networks” The network may
have heterogeneous neighborhood sizes. DDLab has been used for analysis
of gene regulatory networks [S+]. It is free for academic use and can be
obtained from http://www.santafe.edu/~wuensch/ddlab.html.
Petri net UltraSAN
UltraSAN [MS93] is a simulation and analysis tool for Stochastic Activity
Nets. It allows GUI-driven creation of models, performance analysis and
simulation of these models. In UltraSAN time delays defined by a prob-
ability distribution can be specified for each activity. The tool had been
used before for extracellular signaling cascades [ML97]. It is available at
http://www.crhc.uiuc.edu/UltraSAN/UltraSAN.html.
UltraSAN [MS93] does not support a flatfile input format for model data.
For this reason the data has to be entered manually using the GUI.
Graph layout Otter
Otter [Huf00] is a tool used for visualizing arbitrary network data that
can be expressed as a set of nodes, links or paths. Otter was developed
to handle visualization tasks for a wide variety of Internet data. It is
available at http://www.caida.org/tools/visualization/otter/.
Typesetting LATEX
This document was typeset with help of the TEX typesetting program by
Donald E. Knuth [Knu97] using the LATEX2e macro package and the free
TEX distribution available from MiKTEX at http://www.miktex.org/.
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Appendix B
ABBREVIATIONS
AC adenylate cyclase
ACEDB A C. Elegans Data Base
API application programming interface
CSNDB Cell Signaling Networks Data Base
DBMS database management system
EC enzyme classification
ER endoplasmatic reticulum
HTML hypertext markup language
HTTP hypertext transfer protocoll
IP3 inositol 1,4,5-triphosphate
MAP mitogen activated kinase
NF-κB Nuclear Factor κB
OODB object-oriented database
OODBMS object-oriented database management system
OQL object query language
PI3K phosphatidylinositol 3-kinase
PIP2 phosphatidylinositol 4,5-bisphosphate
PKA protein kinase, type A
SQL standard query language
UML unified modeling language
URL uniform resource locator
WWW world wide web
XML extensible markup language
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Appendix C
PATH ALIGNMENT
CLUSTAL G (1.1) multiple sequence alignment
IL-2@NF-kB|7 ---------------------------------------------MacweMaahmMaareMabzsMabzoMadhjMadrq-------------------------
IL-2@c-Myc|8 ---------------------------------------------MacweMaahmMaareMabzsMabzoMacbrMadugMaaba--------------------
IL-2@STAT5|3 ---------------------------------------------MacweMaahmMadki---------------------------------------------
IL-2@Elk-1|11 ---------------------------------------------MacweMaahmMaareMaazxMabjpMaclqMacxlMacxqMadmlMabtoMabtv-----
IL-2@p21|8 ---------------------------------------------MacweMaahmMaareMaazxMabjpMaclqMacxlMacns--------------------
IL-2@CREB2|7 ---------------------------------------------MacweMaahmMaareMaazxMabjpMadtzMaaao-------------------------
IL-2@c-Fos|7 ---------------------------------------------MacweMaahmMaareMaazxMabjpMadtzMacdy-------------------------
IL-2@AP-1|11 ---------------------------------------------MacweMaahmMaareMaazxMaabmMabskMadgwMacujMadxkMabbxMacry-----
IL-2@Jun|10 ---------------------------------------------MacweMaahmMaareMaazxMaabmMabskMadgwMacujMadxkMabbx----------
IL-3@NF-AT|7 ---------------------------------------------MacwdMacbrMaarjMabzsMacxsMabldMaaas-------------------------
PDGF@NF-AT|8 ----------------------------------------MabbqMabsbMacbrMaarjMabzsMacxsMabldMaaas-------------------------
IL-9@NF-AT|9 -----------------------------------MacvwMaanuMadkmMacbrMaarjMabzsMacxsMabldMaaas-------------------------
IL-10@NF-AT|9 -----------------------------------MaagoMadbqMadkmMacbrMaarjMabzsMacxsMabldMaaas-------------------------
IL-2@NF-AT|7 ---------------------------------------------MacweMaahmMaareMabzsMacxsMabldMaaas-------------------------
TNF-alpha_precursor_@NF-kB|5 --------------------------------------------------MacejMabfbMaaonMadffMadrq------------------------------
TNF-alpha@NF-kB|4 -------------------------------------------------------MabfbMaaonMadffMadrq------------------------------
TNF-alpha_precursor_@NF-AT|6 --------------------------------------------------MacejMabfbMaaonMacusMabldMaaas-------------------------
TNF-alpha@NF-AT|5 -------------------------------------------------------MabfbMaaonMacusMabldMaaas-------------------------
NGF@AP-1|8 -----------------------------------------------------------------MaajkMabenMadvoMabweMaapnMabtoMabbxMacry
NGF@Jun|7 -----------------------------------------------------------------MaajkMabenMadvoMabweMaapnMabtoMabbx-----
NGF@NF-kB|7 -----------------------------------------------------------------MaajkMabenMadvoMabweMaapnMabtoMadrq-----
NGF@Elk-1|7 -----------------------------------------------------------------MaajkMabenMadvoMabweMaapnMabtoMabtv-----
prostaglandin_D2@PPAR-gamma|3 --------------------------------------------------MaarbMaazyMacbq----------------------------------------
IL-4@STAT6|3 -----MacwcMabsuMadkh-------------------------------------------------------------------------------------
L-glutamate@CREB|4 ------------------------------MabmpMaddrMaalrMadqx-------------------------------------------------------
PDGF@CREB|6 --------------------MabbqMabsbMacenMaddrMaalrMadqx-------------------------------------------------------
NRG-2@CREB|4 ------------------------------MadbeMaddrMaalrMadqx-------------------------------------------------------
serotonin@NF-kB|6 -----------------------------------MadekMacblMacfuMacrlMadxkMadrq----------------------------------------
serotonin@Elk-1|9 -----------------------------------MadekMacblMacfuMacrlMadxkMacxqMadmlMabtoMabtv-------------------------
serotonin@AP-1|7 -----------------------------------MadekMacblMacfuMacrlMadxkMabbxMacry-----------------------------------
serotonin@Jun|6 -----------------------------------MadekMacblMacfuMacrlMadxkMabbx----------------------------------------
serotonin@NF-AT|9 -----------------------------------MadekMacblMacfuMacrlMaaejMacxlMacxsMabldMaaas-------------------------
serotonin@p21|7 -----------------------------------MadekMacblMacfuMacrlMaaejMacxlMacns-----------------------------------
serotonin@c-Myc|9 -----------------------------------MadekMacblMacfuMacrlMaaejMacxlMacbrMadugMaaba-------------------------
IL-12@STAT4|3 --------------------MaagnMaazwMadkk----------------------------------------------------------------------
IL-3@NF-kB|7 ---------------------------------------------MacwdMacbrMaarjMabzsMabzoMadhjMadrq-------------------------
PDGF@NF-kB|8 ----------------------------------------MabbqMabsbMacbrMaarjMabzsMabzoMadhjMadrq-------------------------
IL-3@c-Myc|4 ---------------------------------------------MacwdMacbrMadugMaaba----------------------------------------
PDGF@c-Myc|5 ----------------------------------------MabbqMabsbMacbrMadugMaaba----------------------------------------
IL-3@AP-1|9 ---------------------------------------------MacwdMacbrMaclqMacxlMacxqMadmlMabtoMabbxMacry---------------
IL-3@Jun|8 ---------------------------------------------MacwdMacbrMaclqMacxlMacxqMadmlMabtoMabbx--------------------
IL-3@Elk-1|8 ---------------------------------------------MacwdMacbrMaclqMacxlMacxqMadmlMabtoMabtv--------------------
IL-3@p21|5 ---------------------------------------------MacwdMacbrMaclqMacxlMacns-----------------------------------
PDGF@AP-1|10 ----------------------------------------MabbqMabsbMacbrMaclqMacxlMacxqMadmlMabtoMabbxMacry---------------
PDGF@Jun|9 ----------------------------------------MabbqMabsbMacbrMaclqMacxlMacxqMadmlMabtoMabbx--------------------
PDGF@Elk-1|9 ----------------------------------------MabbqMabsbMacbrMaclqMacxlMacxqMadmlMabtoMabtv--------------------
PDGF@p21|6 ----------------------------------------MabbqMabsbMacbrMaclqMacxlMacns-----------------------------------
IL-9@STAT3|3 -----------------------------------MacvwMaanuMadkm-------------------------------------------------------
IL-9@NF-kB|9 -----------------------------------MacvwMaanuMadkmMacbrMaarjMabzsMabzoMadhjMadrq-------------------------
IL-9@c-Myc|6 -----------------------------------MacvwMaanuMadkmMacbrMadugMaaba----------------------------------------
IL-9@AP-1|11 -----------------------------------MacvwMaanuMadkmMacbrMaclqMacxlMacxqMadmlMabtoMabbxMacry---------------
IL-9@Jun|10 -----------------------------------MacvwMaanuMadkmMacbrMaclqMacxlMacxqMadmlMabtoMabbx--------------------
IL-9@Elk-1|10 -----------------------------------MacvwMaanuMadkmMacbrMaclqMacxlMacxqMadmlMabtoMabtv--------------------
IL-9@p21|7 -----------------------------------MacvwMaanuMadkmMacbrMaclqMacxlMacns-----------------------------------
IL-10@STAT3|3 -----------------------------------MaagoMadbqMadkm-------------------------------------------------------
IL-10@NF-kB|9 -----------------------------------MaagoMadbqMadkmMacbrMaarjMabzsMabzoMadhjMadrq-------------------------
IL-10@c-Myc|6 -----------------------------------MaagoMadbqMadkmMacbrMadugMaaba----------------------------------------
IL-10@AP-1|11 -----------------------------------MaagoMadbqMadkmMacbrMaclqMacxlMacxqMadmlMabtoMabbxMacry---------------
IL-10@Jun|10 -----------------------------------MaagoMadbqMadkmMacbrMaclqMacxlMacxqMadmlMabtoMabbx--------------------
IL-10@Elk-1|10 -----------------------------------MaagoMadbqMadkmMacbrMaclqMacxlMacxqMadmlMabtoMabtv--------------------
IL-10@p21|7 -----------------------------------MaagoMadbqMadkmMacbrMaclqMacxlMacns-----------------------------------
IL-10@STAT1|3 -----------------------------------MaagoMadbqMadko-------------------------------------------------------
acetylcholine@CREB|7 -----MaaezMadtyMadigMabswMaaloMaafdMadqx-----------------------------------------------------------------
acetylcholine@CREB1|7 -----MaaezMadtyMadigMabswMaaloMaafdMaaaq-----------------------------------------------------------------
acetylcholine@NF-kB|10 -----MaaezMadtyMadigMabswMaaloMaafdMadgwMacujMadxkMadrq--------------------------------------------------
acetylcholine@AP-1|11 -----MaaezMadtyMadigMabswMaaloMaafdMadgwMacujMadxkMabbxMacry---------------------------------------------
acetylcholine@Jun|10 -----MaaezMadtyMadigMabswMaaloMaafdMadgwMacujMadxkMabbx--------------------------------------------------
97
98 APPENDIX C. PATH ALIGNMENT
adrenaline@CREB|7 -----MaavqMacoxMadigMabswMaaloMaafdMadqx-----------------------------------------------------------------
adrenaline@CREB1|7 -----MaavqMacoxMadigMabswMaaloMaafdMaaaq-----------------------------------------------------------------
adrenaline@NF-kB|10 -----MaavqMacoxMadigMabswMaaloMaafdMadgwMacujMadxkMadrq--------------------------------------------------
adrenaline@AP-1|11 -----MaavqMacoxMadigMabswMaaloMaafdMadgwMacujMadxkMabbxMacry---------------------------------------------
adrenaline@Jun|10 -----MaavqMacoxMadigMabswMaaloMaafdMadgwMacujMadxkMabbx--------------------------------------------------
adrenaline@CREB2|7 -----MaavqMacoxMadigMabswMaaloMadtzMaaao-----------------------------------------------------------------
adrenaline@c-Fos|7 -----MaavqMacoxMadigMabswMaaloMadtzMacdy-----------------------------------------------------------------
acetylcholine@CREB2|7 -----MaaezMadtyMadigMabswMaaloMadtzMaaao-----------------------------------------------------------------
ACTH@NF-kB|10 -----MacckMacqpMaafqMabswMaaloMaafdMadgwMacujMadxkMadrq--------------------------------------------------
CRH@NF-kB|11 MadnaMacckMacqpMaafqMabswMaaloMaafdMadgwMacujMadxkMadrq--------------------------------------------------
ACTH@AP-1|11 -----MacckMacqpMaafqMabswMaaloMaafdMadgwMacujMadxkMabbxMacry---------------------------------------------
CRH@AP-1|12 MadnaMacckMacqpMaafqMabswMaaloMaafdMadgwMacujMadxkMabbxMacry---------------------------------------------
ACTH@Jun|10 -----MacckMacqpMaafqMabswMaaloMaafdMadgwMacujMadxkMabbx--------------------------------------------------
CRH@Jun|11 MadnaMacckMacqpMaafqMabswMaaloMaafdMadgwMacujMadxkMabbx--------------------------------------------------
ACTH@Elk-1|13 -----MacckMacqpMaafqMabswMaaloMaafdMadgwMacujMadxkMacxqMadmlMabtoMabtv-----------------------------------
CRH@Elk-1|14 MadnaMacckMacqpMaafqMabswMaaloMaafdMadgwMacujMadxkMacxqMadmlMabtoMabtv-----------------------------------
ACTH@CREB|7 -----MacckMacqpMaafqMabswMaaloMaafdMadqx-----------------------------------------------------------------
CRH@CREB|8 MadnaMacckMacqpMaafqMabswMaaloMaafdMadqx-----------------------------------------------------------------
ACTH@CREB1|7 -----MacckMacqpMaafqMabswMaaloMaafdMaaaq-----------------------------------------------------------------
CRH@CREB1|8 MadnaMacckMacqpMaafqMabswMaaloMaafdMaaaq-----------------------------------------------------------------
ACTH@NF-AT|11 -----MacckMacqpMaafqMabswMaaloMaafdMadgwMacujMabauMaajhMaaas---------------------------------------------
CRH@NF-AT|12 MadnaMacckMacqpMaafqMabswMaaloMaafdMadgwMacujMabauMaajhMaaas---------------------------------------------
ACTH@CREB2|7 -----MacckMacqpMaafqMabswMaaloMadtzMaaao-----------------------------------------------------------------
CRH@CREB2|8 MadnaMacckMacqpMaafqMabswMaaloMadtzMaaao-----------------------------------------------------------------
ACTH@c-Fos|7 -----MacckMacqpMaafqMabswMaaloMadtzMacdy-----------------------------------------------------------------
CRH@c-Fos|8 MadnaMacckMacqpMaafqMabswMaaloMadtzMacdy-----------------------------------------------------------------
GH-RH@AP-1|11 -----MachzMadkxMaafqMabswMaaloMaafdMadgwMacujMadxkMabbxMacry---------------------------------------------
GH-RH@Jun|10 -----MachzMadkxMaafqMabswMaaloMaafdMadgwMacujMadxkMabbx--------------------------------------------------
GH-RH@NF-kB|10 -----MachzMadkxMaafqMabswMaaloMaafdMadgwMacujMadxkMadrq--------------------------------------------------
GH-RH@Elk-1|13 -----MachzMadkxMaafqMabswMaaloMaafdMadgwMacujMadxkMacxqMadmlMabtoMabtv-----------------------------------
GH-RH@CREB|7 -----MachzMadkxMaafqMabswMaaloMaafdMadqx-----------------------------------------------------------------
GH-RH@NF-AT|11 -----MachzMadkxMaafqMabswMaaloMaafdMadgwMacujMabauMaajhMaaas---------------------------------------------
GH-RH@CREB1|7 -----MachzMadkxMaafqMabswMaaloMaafdMaaaq-----------------------------------------------------------------
GH-RH@CREB2|7 -----MachzMadkxMaafqMabswMaaloMadtzMaaao-----------------------------------------------------------------
GH-RH@c-Fos|7 -----MachzMadkxMaafqMabswMaaloMadtzMacdy-----------------------------------------------------------------
serotonin@CREB|6 ----------MadekMabwiMabswMaaloMaafdMadqx-----------------------------------------------------------------
serotonin@CREB1|6 ----------MadekMabwiMabswMaaloMaafdMaaaq-----------------------------------------------------------------
serotonin@CREB2|6 ----------MadekMabwiMabswMaaloMadtzMaaao-----------------------------------------------------------------
serotonin@c-Fos|6 ----------MadekMabwiMabswMaaloMadtzMacdy-----------------------------------------------------------------
adenosine@NF-kB|9 ----------MaahbMaadwMabswMaaloMaafdMadgwMacujMadxkMadrq--------------------------------------------------
adenosine@Elk-1|12 ----------MaahbMaadwMabswMaaloMaafdMadgwMacujMadxkMacxqMadmlMabtoMabtv-----------------------------------
adenosine@AP-1|10 ----------MaahbMaadwMabswMaaloMaafdMadgwMacujMadxkMabbxMacry---------------------------------------------
adenosine@Jun|9 ----------MaahbMaadwMabswMaaloMaafdMadgwMacujMadxkMabbx--------------------------------------------------
adenosine@CREB|6 ----------MaahbMaadwMabswMaaloMaafdMadqx-----------------------------------------------------------------
adenosine@NF-AT|10 ----------MaahbMaadwMabswMaaloMaafdMadgwMacujMabauMaajhMaaas---------------------------------------------
adenosine@CREB1|6 ----------MaahbMaadwMabswMaaloMaafdMaaaq-----------------------------------------------------------------
adenosine@CREB2|6 ----------MaahbMaadwMabswMaaloMadtzMaaao-----------------------------------------------------------------
adenosine@c-Fos|6 ----------MaahbMaadwMabswMaaloMadtzMacdy-----------------------------------------------------------------
acetylcholine@c-Fos|3 -----MaaezMadtyMacdy-------------------------------------------------------------------------------------
acetylcholine@Elk-1|11 ------------------------------MaaezMadtyMadigMaaffMacktMaclqMacxlMacxqMadmlMabtoMabtv--------------------
adrenaline@Elk-1|11 ------------------------------MaavqMacoxMadigMaaffMacktMaclqMacxlMacxqMadmlMabtoMabtv--------------------
acetylcholine@NF-AT|10 ------------------------------MaaezMadtyMadigMaaffMacktMaclqMacxlMacxsMabldMaaas-------------------------
acetylcholine@p21|8 ------------------------------MaaezMadtyMadigMaaffMacktMaclqMacxlMacns-----------------------------------
acetylcholine@c-Myc|10 ------------------------------MaaezMadtyMadigMaaffMacktMaclqMacxlMacbrMadugMaaba-------------------------
adrenaline@NF-AT|10 ------------------------------MaavqMacoxMadigMaaffMacktMaclqMacxlMacxsMabldMaaas-------------------------
adrenaline@p21|8 ------------------------------MaavqMacoxMadigMaaffMacktMaclqMacxlMacns-----------------------------------
adrenaline@c-Myc|10 ------------------------------MaavqMacoxMadigMaaffMacktMaclqMacxlMacbrMadugMaaba-------------------------
ACTH@c-Myc|15 -----MacckMacqpMaafqMabswMaaloMaafdMabynMadigMaaffMacktMaclqMacxlMacbrMadugMaaba-------------------------
CRH@c-Myc|16 MadnaMacckMacqpMaafqMabswMaaloMaafdMabynMadigMaaffMacktMaclqMacxlMacbrMadugMaaba-------------------------
ACTH@p21|13 -----MacckMacqpMaafqMabswMaaloMaafdMabynMadigMaaffMacktMaclqMacxlMacns-----------------------------------
CRH@p21|14 MadnaMacckMacqpMaafqMabswMaaloMaafdMabynMadigMaaffMacktMaclqMacxlMacns-----------------------------------
adenosine@c-Myc|14 ----------MaahbMaadwMabswMaaloMaafdMabynMadigMaaffMacktMaclqMacxlMacbrMadugMaaba-------------------------
adenosine@p21|12 ----------MaahbMaadwMabswMaaloMaafdMabynMadigMaaffMacktMaclqMacxlMacns-----------------------------------
GH-RH@c-Myc|15 -----MachzMadkxMaafqMabswMaaloMaafdMabynMadigMaaffMacktMaclqMacxlMacbrMadugMaaba-------------------------
GH-RH@p21|13 -----MachzMadkxMaafqMabswMaaloMaafdMabynMadigMaaffMacktMaclqMacxlMacns-----------------------------------
EGF@AP-1|10 ----------------------------------------MaczjMadbwMabjpMaclqMacxlMacxqMadmlMabtoMabbxMacry---------------
EGF@Jun|9 ----------------------------------------MaczjMadbwMabjpMaclqMacxlMacxqMadmlMabtoMabbx--------------------
EGF@NF-kB|9 ----------------------------------------MaczjMadbwMabjpMaclqMacxlMacxqMadmlMabtoMadrq--------------------
EGF@Elk-1|9 ----------------------------------------MaczjMadbwMabjpMaclqMacxlMacxqMadmlMabtoMabtv--------------------
EGF@NF-AT|8 ----------------------------------------MaczjMadbwMabjpMaclqMacxlMacxsMabldMaaas-------------------------
EGF@p21|6 ----------------------------------------MaczjMadbwMabjpMaclqMacxlMacns-----------------------------------
EGF@c-Myc|8 ----------------------------------------MaczjMadbwMabjpMaclqMacxlMacbrMadugMaaba-------------------------
EGF@CREB2|5 ----------------------------------------MaczjMadbwMabjpMadtzMaaao----------------------------------------
EGF@c-Fos|5 ----------------------------------------MaczjMadbwMabjpMadtzMacdy----------------------------------------
IL-1@NF-kB|7 --------------------MacwfMabhkMacunMaaisMabtgMadlaMadrq--------------------------------------------------
. : : . . .
ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/MAPK cascade/CREB2
ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/MAPK cascade/c-Fos
ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/CREB1
ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/CREB
ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/calmodulin/calcineurin/NF-AT
ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Jun
ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Jun/AP-1
ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/NF-kB
ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/beta-adrenergic receptor/Gi/G-gamma/Src/Sos/Ras/PI3-kinase/PKB/c-Myc
ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/beta-adrenergic receptor/Gi/G-gamma/Src/Sos/Ras/p21
CRH/ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/MAPK cascade/CREB2
CRH/ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/MAPK cascade/c-Fos
CRH/ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/CREB1
CRH/ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/CREB
CRH/ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/calmodulin/calcineurin/NF-AT
CRH/ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Jun
CRH/ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Jun/AP-1
CRH/ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/NF-kB
CRH/ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
CRH/ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/beta-adrenergic receptor/Gi/G-gamma/Src/Sos/Ras/PI3-kinase/PKB/c-Myc: 16
CRH/ACTH/ACTH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/beta-adrenergic receptor/Gi/G-gamma/Src/Sos/Ras/p21
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EGF/EGF receptor/Grb2/MAPK cascade/CREB2
EGF/EGF receptor/Grb2/MAPK cascade/c-Fos
EGF/EGF receptor/Grb2/Sos/Ras/PI3-kinase/PKB/c-Myc
EGF/EGF receptor/Grb2/Sos/Ras/Rac/JNK/NF-AT
EGF/EGF receptor/Grb2/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
EGF/EGF receptor/Grb2/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Jun
EGF/EGF receptor/Grb2/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Jun/AP-1
EGF/EGF receptor/Grb2/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/NF-kB
EGF/EGF receptor/Grb2/Sos/Ras/p21
GH-RH/GH-RH receptor/G-alpha-s/adenylyl cyclase/cAMP/MAPK cascade/CREB2
GH-RH/GH-RH receptor/G-alpha-s/adenylyl cyclase/cAMP/MAPK cascade/c-Fos
GH-RH/GH-RH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/CREB1
GH-RH/GH-RH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/CREB
GH-RH/GH-RH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/calmodulin/calcineurin/NF-AT
GH-RH/GH-RH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Jun
GH-RH/GH-RH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Jun/AP-1
GH-RH/GH-RH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/NF-kB
GH-RH/GH-RH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
GH-RH/GH-RH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/beta-adrenergic receptor/Gi/G-gamma/Src/Sos/Ras/PI3-kinase/PKB/c-Myc
GH-RH/GH-RH receptor/G-alpha-s/adenylyl cyclase/cAMP/Protein Kinase A/beta-adrenergic receptor/Gi/G-gamma/Src/Sos/Ras/p21
IL-10/IL-10 receptor/STAT1
IL-10/IL-10 receptor/STAT3
IL-10/IL-10 receptor/STAT3/PI3-kinase/PKB/c-Myc
IL-10/IL-10 receptor/STAT3/PI3-kinase/PtdIns(3,4,5)P3/VAV/Rac-1/reactive oxygen species/NF-kB
IL-10/IL-10 receptor/STAT3/PI3-kinase/PtdIns(3,4,5)P3/VAV/Rac/JNK/NF-AT
IL-10/IL-10 receptor/STAT3/PI3-kinase/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
IL-10/IL-10 receptor/STAT3/PI3-kinase/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Jun
IL-10/IL-10 receptor/STAT3/PI3-kinase/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Jun/AP-1
IL-10/IL-10 receptor/STAT3/PI3-kinase/Sos/Ras/p21
IL-12/IL-12 receptor/STAT4
IL-1/IL-1 receptor/TRAF6/NIK/IKK/I-kB/NF-kB
IL-2/IL-2 receptor/Lck/LAT/Grb2/MAPK cascade/CREB2
IL-2/IL-2 receptor/Lck/LAT/Grb2/MAPK cascade/c-Fos
IL-2/IL-2 receptor/Lck/LAT/Grb2/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
IL-2/IL-2 receptor/Lck/LAT/Grb2/Sos/Ras/p21
IL-2/IL-2 receptor/Lck/LAT/PLC-gamma1/IP3/IP3 receptor/Ca(II)/protein kinase C/Jun
IL-2/IL-2 receptor/Lck/LAT/PLC-gamma1/IP3/IP3 receptor/Ca(II)/protein kinase C/Jun/AP-1
IL-2/IL-2 receptor/Lck/VAV/Rac-1/PI3-kinase/PKB/c-Myc
IL-2/IL-2 receptor/Lck/VAV/Rac-1/reactive oxygen species/NF-kB
IL-2/IL-2 receptor/Lck/VAV/Rac/JNK/NF-AT
IL-2/IL-2 receptor/STAT5
IL-3/PI3-kinase/PKB/c-Myc
IL-3/PI3-kinase/PtdIns(3,4,5)P3/VAV/Rac-1/reactive oxygen species/NF-kB
IL-3/PI3-kinase/PtdIns(3,4,5)P3/VAV/Rac/JNK/NF-AT
IL-3/PI3-kinase/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
IL-3/PI3-kinase/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Jun
IL-3/PI3-kinase/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Jun/AP-1
IL-3/PI3-kinase/Sos/Ras/p21
IL-4/IL-4 receptor/STAT6
IL-9/IL-9 receptor/STAT3
IL-9/IL-9 receptor/STAT3/PI3-kinase/PKB/c-Myc
IL-9/IL-9 receptor/STAT3/PI3-kinase/PtdIns(3,4,5)P3/VAV/Rac-1/reactive oxygen species/NF-kB
IL-9/IL-9 receptor/STAT3/PI3-kinase/PtdIns(3,4,5)P3/VAV/Rac/JNK/NF-AT
IL-9/IL-9 receptor/STAT3/PI3-kinase/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
IL-9/IL-9 receptor/STAT3/PI3-kinase/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Jun
IL-9/IL-9 receptor/STAT3/PI3-kinase/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Jun/AP-1
IL-9/IL-9 receptor/STAT3/PI3-kinase/Sos/Ras/p21
L-glutamate/NMDA receptor/CaMKIV/CREB
NGF/CREB
NGF/NGF receptor/C3G/Rap1/B-Raf/MAP-kinase/Elk-1
NGF/NGF receptor/C3G/Rap1/B-Raf/MAP-kinase/Jun
NGF/NGF receptor/C3G/Rap1/B-Raf/MAP-kinase/Jun/AP-1
NGF/NGF receptor/C3G/Rap1/B-Raf/MAP-kinase/NF-kB
NRG-2/NMDA receptor/CaMKIV/CREB
PDGF/PDGF receptor/Fyn/NMDA receptor/CaMKIV/CREB
PDGF/PDGF receptor/PI3-kinase/PKB/c-Myc
PDGF/PDGF receptor/PI3-kinase/PtdIns(3,4,5)P3/VAV/Rac-1/reactive oxygen species/NF-kB
PDGF/PDGF receptor/PI3-kinase/PtdIns(3,4,5)P3/VAV/Rac/JNK/NF-AT
PDGF/PDGF receptor/PI3-kinase/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
PDGF/PDGF receptor/PI3-kinase/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Jun
PDGF/PDGF receptor/PI3-kinase/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Jun/AP-1
PDGF/PDGF receptor/PI3-kinase/Sos/Ras/p21
SRPK1/SR proteins
TNF-alpha(precursor)/TNF-alpha/TNF receptor1/DR3/NF-kB
TNF-alpha(precursor)/TNF-alpha/TNF receptor1/TRAF2/JNK/NF-AT
TNF-alpha/TNF receptor1/DR3/NF-kB
TNF-alpha/TNF receptor1/TRAF2/JNK/NF-AT
WSL-1/NF-kB
acetylcholine/muscarinic acetylcholine receptor/Gi/G-gamma/Src/Sos/Ras/PI3-kinase/PKB/c-Myc
acetylcholine/muscarinic acetylcholine receptor/Gi/G-gamma/Src/Sos/Ras/Rac/JNK/NF-AT
acetylcholine/muscarinic acetylcholine receptor/Gi/G-gamma/Src/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
acetylcholine/muscarinic acetylcholine receptor/Gi/G-gamma/Src/Sos/Ras/p21
acetylcholine/muscarinic acetylcholine receptor/Gi/adenylyl cyclase/cAMP/MAPK cascade/CREB2
acetylcholine/muscarinic acetylcholine receptor/Gi/adenylyl cyclase/cAMP/Protein Kinase A/CREB1
acetylcholine/muscarinic acetylcholine receptor/Gi/adenylyl cyclase/cAMP/Protein Kinase A/CREB
acetylcholine/muscarinic acetylcholine receptor/Gi/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Jun
acetylcholine/muscarinic acetylcholine receptor/Gi/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Jun/AP-1
acetylcholine/muscarinic acetylcholine receptor/Gi/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/NF-kB
acetylcholine/muscarinic acetylcholine receptor/c-Fos
activin/FAST-1
adenosine/A2b receptor/adenylyl cyclase/cAMP/MAPK cascade/CREB2
adenosine/A2b receptor/adenylyl cyclase/cAMP/MAPK cascade/c-Fos
adenosine/A2b receptor/adenylyl cyclase/cAMP/Protein Kinase A/CREB1
adenosine/A2b receptor/adenylyl cyclase/cAMP/Protein Kinase A/CREB
adenosine/A2b receptor/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/calmodulin/calcineurin/NF-AT
adenosine/A2b receptor/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Jun
adenosine/A2b receptor/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Jun/AP-1
adenosine/A2b receptor/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/NF-kB
adenosine/A2b receptor/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
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adenosine/A2b receptor/adenylyl cyclase/cAMP/Protein Kinase A/beta-adrenergic receptor/Gi/G-gamma/Src/Sos/Ras/PI3-kinase/PKB/c-Myc
adenosine/A2b receptor/adenylyl cyclase/cAMP/Protein Kinase A/beta-adrenergic receptor/Gi/G-gamma/Src/Sos/Ras/p21
adrenaline/alpha2-adrenergic receptor/Gi/G-gamma/Src/Sos/Ras/PI3-kinase/PKB/c-Myc
adrenaline/alpha2-adrenergic receptor/Gi/G-gamma/Src/Sos/Ras/Rac/JNK/NF-AT
adrenaline/alpha2-adrenergic receptor/Gi/G-gamma/Src/Sos/Ras/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
adrenaline/alpha2-adrenergic receptor/Gi/G-gamma/Src/Sos/Ras/p21
adrenaline/alpha2-adrenergic receptor/Gi/adenylyl cyclase/cAMP/MAPK cascade/CREB2
adrenaline/alpha2-adrenergic receptor/Gi/adenylyl cyclase/cAMP/MAPK cascade/c-Fos
adrenaline/alpha2-adrenergic receptor/Gi/adenylyl cyclase/cAMP/Protein Kinase A/CREB1
adrenaline/alpha2-adrenergic receptor/Gi/adenylyl cyclase/cAMP/Protein Kinase A/CREB
adrenaline/alpha2-adrenergic receptor/Gi/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Jun
adrenaline/alpha2-adrenergic receptor/Gi/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/Jun/AP-1
adrenaline/alpha2-adrenergic receptor/Gi/adenylyl cyclase/cAMP/Protein Kinase A/IP3 receptor/Ca(II)/protein kinase C/NF-kB
cortisol/glucocorticoid receptor
estradiol/AP-1
estradiol/ERE
estradiol/estrogen receptor
glucocorticoid/glucocorticoid receptor
progesterone/progesterone receptor
prostaglandin D2/15d-PGJ2/PPAR-gamma
retinoic acid/p21
retinoic acid/retinoic acid receptor
serotonin/5-HT2CR/phospholipase C/diacylglycerol/GNRP/Ras/PI3-kinase/PKB/c-Myc
serotonin/5-HT2CR/phospholipase C/diacylglycerol/GNRP/Ras/Rac/JNK/NF-AT
serotonin/5-HT2CR/phospholipase C/diacylglycerol/GNRP/Ras/p21
serotonin/5-HT2CR/phospholipase C/diacylglycerol/protein kinase C/Jun
serotonin/5-HT2CR/phospholipase C/diacylglycerol/protein kinase C/Jun/AP-1
serotonin/5-HT2CR/phospholipase C/diacylglycerol/protein kinase C/NF-kB
serotonin/5-HT2CR/phospholipase C/diacylglycerol/protein kinase C/Raf/MAP-kinase-kinase/MAP-kinase/Elk-1
serotonin/serotonin receptor/adenylyl cyclase/cAMP/MAPK cascade/CREB2
serotonin/serotonin receptor/adenylyl cyclase/cAMP/MAPK cascade/c-Fos
serotonin/serotonin receptor/adenylyl cyclase/cAMP/Protein Kinase A/CREB1
serotonin/serotonin receptor/adenylyl cyclase/cAMP/Protein Kinase A/CREB
thyroxine/thyroxine receptor
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PETRI NET
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Table D.1: Non-zero or Variable Initial Markings for SAN Model A EGFR
Place Marking
EGF GLOBAL S(egf)
EGFR 166
EGF EGFR GLOBAL S(egf egfr)
GDP Ras GLOBAL S(gdp ras)
GRB2 1000
GTP Ras GLOBAL S(gtp ras)
MAPK X GLOBAL S(mapk x)
SHC 500
SOS 100
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Table D.2: Activity Time Distributions for SAN Model A EGFR
Activity Distribution Parameter values
A1 exponential
rate MARK(EGF) ∗
MARK(EGFR) ∗
0.007
A10 exponential
rate MARK(SOS X) ∗
MARK(GRB2) ∗
0.000041667
A10B exponential
rate 0.0168 ∗
MARK(SOS X GRB2)
A1B exponential
rate 0.25 ∗
MARK(EGF EGFR)
A2 exponential
rate 0.002 ∗
MARK(EGF EGFR)
A2B exponential
rate MARK(EGF EGFR INTERNAL) ∗
0.00033
A3 exponential
rate 0.2 ∗
MARK(EGF EGFR) ∗
MARK(SHC) /
(833 + MARK(SHC))
A4 exponential
rate 0.0016667 ∗
MARK(SHC X)
A5 exponential
rate MARK(SOS) ∗
MARK(GRB2) ∗
0.000041667
A5B exponential
rate 0.0168 ∗
MARK(SOS GRB2)
A6 exponential
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Table D.3: Activity Time Distributions for SAN Model A EGFR
Activity Distribution Parameter values
rate MARK(SHC X) ∗
MARK(SOS GRB2) ∗
0.000833
A6B exponential
rate 0.1 ∗
MARK(SHC X SOS GRB2)
A7 exponential
rate 0.02 ∗
MARK(SHC X SOS GRB2) ∗
MARK(GDP Ras) /
(505 + MARK(GDP Ras))
A8 exponential
rate MARK(SOS X) ∗
0.001
A9 exponential
rate 10 ∗ MARK(MAPK X) ∗
MARK(SOS) /
(2564 + MARK(SOS))
Table D.4: Non-zero or Variable Initial Markings for SAN Model H MAPK
Place Marking
MAPK 360
MAPKK 180
MAPK X GLOBAL S(mapk x)
MKP1 3
PKC GLOBAL S(pkc)
PP2 A 224
Raf 200
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Table D.5: Activity Time Distributions for SAN Model H MAPK
Activity Distribution Parameter values
H1 exponential
rate 4.0 ∗ MARK(PKC) ∗
MARK(Raf) /
(66666.0 + MARK(Raf))
H10 exponential
rate 0.15 ∗ MARK(MAPKK XX) ∗
MARK(MAPK) /
(46.0 + MARK(MAPK))
H11 exponential
rate 0.15 ∗ MARK(MAPKK XX) ∗
MARK(MAPKtyr X) /
(46.0 + MARK(MAPKtyr X))
H12 exponential
rate 1.0 ∗ MARK(MKP1) ∗
MARK(MAPKtyr X) /
(66.0 + MARK(MAPKtyr X))
H13 exponential
rate 1.0 ∗ MARK(MKP1) ∗
MARK(MAPK X) /
(66.0 + MARK(MAPK X))
H2 exponential
rate 10.0 ∗ MARK(MAPK X) ∗
MARK(Raf X) /
(25641.0 + MARK(Raf X))
H3 exponential
rate 6.0 ∗ MARK(PP2 A) ∗
MARK(Raf X) /
(15656.0 ∗ MARK(Raf X))
H4 exponential
rate 6.0 ∗ MARK(PP2 A) ∗
MARK(Raf XX) /
(15656.0 ∗ MARK(Raf XX))
H5 exponential
rate 0.04 ∗
MARK(GTP Ras) ∗
MARK(Raf X)
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Table D.6: Activity Time Distributions for SAN Model H MAPK
Activity Distribution Parameter values
H5B exponential
rate 0.5 ∗
MARK(GTP Ras Raf X)
H6 exponential
rate 0.105 ∗
MARK(GTP Ras Raf X) ∗
MARK(MAPKK) /
(159.0 + MARK(MAPKK))
H7 exponential
rate 0.105 ∗
MARK(GTP Ras Raf X) ∗
MARK(MAPKK X) /
(159.0 + MARK(MAPKK X))
H8 exponential
rate 6.0 ∗ MARK(PP2 A) ∗
MARK(MAPKK X) /
(15656.0 + MARK(MAPKK X))
H9 exponential
rate 6.0 ∗ MARK(PP2 A) ∗
MARK(MAPKK XX) /
(15656.0 + MARK(PP2 A))
Table D.7: Activity Time Distributions for SAN Model O CLOCK
Activity Distribution Parameter values
Tick deterministic
value 1
Table D.8: Output Gate Definitions for SAN Model O CLOCK
Gate Definition
limit if (MARK(Clock) > GLOBAL S(stimulus time)) {
MARK(Clock) = 0;
} else {
MARK(Clock) = MARK(Clock) + 2;
MARK(EGF) = GLOBAL S(egf);
}
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